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On 2 July 2020, Frank Feighan TD for Sligo-Leitrim was 
appointed Minister of State for Public Health, Well Being and 
National Drugs Strategy. This follows on from the publication 
of Programme for Government: our shared future.1 The new 
Programme for Government commits to taking a health-
led approach to drugs misuse and continuing to deliver on 
the existing national drugs strategy (NDS), Reducing Harm, 
Supporting Recovery (2017–2025).2
The new Government divides its commitments into a set of four and a further 
set of 24 actions, all of which are in line with the NDS.2 The reason for having two 
separate sets is unclear; hence, they are dealt with together for the purpose of 
this article. Where relevant, the article puts them in the context of the existing 
strategic action plan for 2017–2020 embedded in the NDS.
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In brief
Effective monitoring and reliable data are essential for economic 
and health planning and for supporting an informed and politically 
active citizenry. The constant updates on the impact of the 
Covid pandemic help us to keep informed, but they can also be 
wearying, and their contribution to our knowledge depends on 
our capacity to absorb difficult information. 
Our understanding of the drug situation faces a different problem. The data 
systems that we depend on to provide detailed analysis of the nature of drug 
use and its consequences are, by necessity, slow to provide the information we 
need to observe trends, plan responses, and develop policy. In recent years, early 
warning systems, innovations such as wastewater analysis and open source media 
monitoring, and research developments like trendspotting have helped to make 
information more rapidly available.
The methodological advances complement rather than replace the information 
from prevalence studies and established treatment and harm-reduction 
information systems. In September 2020, the European Monitoring Centre for 
Drugs and Drug Addiction (EMCDDA) published its annual European drug report, 
largely based on analysis of aggregated data from 29 countries in the European 
Union’s Reitox drug-monitoring network.1 It also includes more recent information 
on the disruption caused by Covid-19 among support services to people who 
use drugs. There are discernible changes in patterns describing synthetic drug 
production and in the distribution routes used for the bulk supply of cocaine, 
heroin, and cannabis.
We have seen that Ireland and other countries responded quickly and were able 
to lessen the impact of Covid-19 on the most vulnerable populations. Important 
harm reductions lessons were learned. Security services also have faced new 
problems as restrictions forced those involved in drug distribution to develop new 
approaches to supply and create new markets as demand fell sharply, particularly 
in the night-time economy. The report identifies other important supply-related 
changes that predate the pandemic but may have accelerated over the last 
several months. It is clear from seizure figures that large quantities of cocaine 
are coming into Europe to meet an increasing demand. Also, analysis of drugs 
seized show that the purity of cocaine is rising, posing greater danger to public 
health. Cannabis too is increasing in potency and typically the levels of THC, the 
psychoactive part of cannabis, are double what they were 10 years ago.
The EMCDDA’s first report on aggregated estimates was the Annual report on the 
state of the drugs problem in the European Union 1995. So, this year marks 25 
years of European-wide reporting on the drugs problem. As the agency’s scientific 
director explains, the evolution of the drugs problem during that time was 
accompanied by a dramatic increase in the quantity and quality of the information 
on this topic.2 The European drug report presents an opportunity to compare 
the situation in Ireland with the rest of Europe.3 It also enables us to observe 
trends and patterns based on systematically collected and expertly analysed data. 
While each country has its idiosyncrasies, the cultural and demographic features 
determining drug-using behaviour are broadly similar. It is important that we keep 
this greater picture in mind when anticipating developments in our own context 
and planning responses to it.
 
1 European Monitoring Centre for Drugs and Drug Addiction (2020) European drug 
report 2020: trends and developments. Luxembourg: Publications Office of the 
European Union. https://www.drugsandalcohol.ie/33049/
2  Griffiths P (2020) Looking back on 25 years of annual reporting on the drugs problem 
in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.
https://www.emcdda.europa.eu/system/files/attachments/13265/Feature_article_
EDR_25years_Final_web.pdf 
3  Health Research Board (HRB) (2020) Health Research Board compares the Irish drug 
situation with the rest of Europe. Dublin: HRB.  
https://www.hrb.ie/news/press-releases/ 
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Programme for Government   
continued
Programme for Government commitments
When examined alongside the strategic action plan (2017–2020), 
most of the commitments in the new Programme for Government 
can be linked to existing actions and reflect progress made on their 
delivery since 2017. While one deals with a specific service (the 
re-establishment of the Galway city community-based alcohol 
treatment service), the others are broader in nature.
New actions
There are some actions that deal with new developments in Irish 
drug policy: a new topic, target group, or approach to addressing 
the needs of people who use drugs. This is not to suggest that there 
has been no activity already in these areas in terms of delivery 
on the ground, rather that they were not part of the 2017–2020 
strategic action plan but reflect changes in the field.
There are seven new actions:
1 A representative of the National Oversight Committee for 
Reducing Harm, Supporting Recovery will be included in the 
implementation and monitoring arrangements for the new 
national mental health policy launched in June 2020, Sharing 
the Vision: a mental health policy for everyone.3
2 The Government will seek to retain the specific actions taken to 
support increased and improved access to opioid substitution 
services during Covid-19, so that pre-Covid waiting times in 
accessing these services are reduced.4
3 The regulations and legislation that apply to cannabis use 
for medical conditions and palliative care, having regard to 
the experience in Northern Ireland and Great Britain, will be 
examined. Cannabis use for medicinal purposes did not feature 
in the strategic action plan for 2017–2020. However, since the 
strategy was launched in 2017, it has been the subject of a 
scientific review and legislation. In 2017, Cannabis for medical 
use: a scientific review5 by the Health Products Regulatory 
Authority was published. On 26 June 2019, legislation was passed 
to allow for a Medical Cannabis Access Programme to operate in 
Ireland on a pilot basis for five years.
4 A citizens’ assembly to consider matters relating to drug use will 
be convened. The development of the NDS involved extensive 
consultation with stakeholders and the public. In line with this, 
the Drugs Policy Unit of the Department of Health and the 
Health Research Board have collaborated on an annual drug 
forum to support evidence-informed practice and service 
delivery; promote participation of communities, service users, 
and their families in national structures; and strengthen the 
implementation and performance of the NDS. 
5 The coercion and use of minors in the sale and supply of drugs 
will be legislated against. This is a new policy commitment for 
Government. A Private Members’ Bill on the topic lapsed in 
January 2020 with the dissolution of the last Government.6
6 A 24-hour helpline, based on the FRANK helpline in the United 
Kingdom, providing advice and assistance to people who use 
drugs and their family members, will be established. As part of 
Drugs.ie, the Health Service Executive currently runs a drug and 
alcohol helpline for anyone with a question or concern related 
to drug and alcohol use. The times are limited to office hours, 
Monday to Friday.
7 A ‘Good Neighbour’ policy for drug treatment centres to 
address any concerns held by local residents and businesses 
alike will be ensured.
Fergus 
McCabe
We were very saddened 
to learn of the recent 
death of Fergus McCabe. 
Fergus was a brilliant 
organiser, advocate, and 
campaigner and brought 
a deep knowledge of 
drugs issues to all his 
work.  He made valuable and incisive contributions to 
successive drugs strategies. He was also an avid reader 
and champion of Drugnet Ireland. We are grateful to 
his friend and colleague, Anna Quigley, coordinator at 
CityWide Drugs Crisis Campaign for the short tribute 
below.
Fergus was a passionate, articulate and tireless 
champion for his own community in the north inner 
city and he brought the same gifts to his work with 
CityWide Drugs Crisis Campaign, of which he was 
a founder member. Over the last 25 years Fergus 
travelled to communities all over Ireland to meet 
with people responding to the drugs crisis; he 
never said no to a meeting if it was possible for him 
to make it. Fergus understood what community 
development is about and he had a gift for it; no 
meeting was too small or too far away. He shared 
his knowledge, wisdom, and experience with all 
of us, and he did it with grace, generosity, and a 
lovely sense of humour ... and of course always a 
comment on Spurs! 
Fergus represented the community sector on 
National Drugs Strategy Committees since 1996 and 
continued as a member of the current National 
Oversight Committee until recently. Throughout 
the many years of his participation on these 
committees, Fergus was a brilliant advocate for our 
communities, strong, passionate, and principled. 
That great phrase  'telling truth to power' could 
have been written for Fergus, because that is what 
he did, and in doing so, he won the respect of many 
of those people in power. He has been a leader, a 
mentor, and an inspiration to me and to countless 
others involved with the community response 
to drugs. Above all else, Fergus was a wonderful 
human being and our thoughts and sympathies are 
with Helena and the family on their profound loss. 
They have always been his light and inspiration. 
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A further four actions indicate a new focus or target group for 
existing actions:
1 The potential for an information campaign on the health 
impacts of steroid use, particularly on young men, will be 
examined. This is a new focus in relation to the existing action 
plan. While people who use steroids were mentioned in the 
existing action plan as a new service-user population at 
needle exchange programmes, steroids were not identified as 
a specific target for prevention and harm reduction activities.
2 That women can face barriers to accessing and sustaining 
addiction treatment, arising from an absence of childcare 
or the presence of domestic violence, will be recognised 
and targeted interventions aimed at responding to their 
needs will be developed. While domestic violence is noted 
as an issue facing women who use drugs in Reducing Harm, 
Supporting Recovery, it does not feature in its action plan. 
Childcare is recognised as a barrier needing to be addressed 
in one of the actions in the plan, but this new action 
recognises other barriers by specifically noting domestic 
violence.
3 Support for step-down accommodation to prevent high-
risk single people and families from exiting treatment 
into homelessness will be significantly increased. This is a 
broadening out of an existing action to include high-risk 
single people.
4 Harm reduction and education campaigns aimed at 
increasing awareness of the risks of drug use and the 
contribution of drugs to criminality will continue to be 
resourced. This is a continuation of existing work but the 
focus on the contribution of drugs to criminality is new.
Commitments to a policy direction
Three of the actions indicate a move from exploring an issue in 
the strategic action plan to a commitment to a particular policy 
position:
1 To increase and support drug-quality testing services, 
particularly at festivals
2 To support the rollout of access to and training in opioid 
antidotes
3 To implement the recommendations of the Working Group 
to Consider Alternative Approaches to the Possession 
of Drugs for Personal Use and to review the alternative 
approach adopted after its first year of implementation 
in order to ensure that it is meeting its aims. However, the 
health diversion approach launched by Government in 
August 2019 as the approach being adopted following the 
Working Group’s report is not referred to specifically in the 
document.
Support for existing actions
Ten of the actions are either the same, variations, or 
continuations of those in the strategic action plan:
1 Build on recent initiatives at Junior and Senior Cycle and 
support secondary schools in introducing drug and alcohol 
awareness programmes, particularly in relation to the 
hazards of casual drug use.
2 Examine approaches to identifying at-risk young people and 
vulnerable groups to interrupt their potential trajectory into 
problem drug and alcohol misuse.
3 Expand services for pregnant and postnatal women affected 
by substance use, and their children.
4 Create a path for people in rehabilitation from drug addiction 
to access education and training facilities in their local areas.
5 Progress the National Clinical Programme for Dual Diagnosis 
and work to develop joint protocols and referral pathways.
6 Support the Drug Related Intimidation Reporting Programme, 
developed by the National Family Support Network, in 
partnership with An Garda Síochána, to respond to the needs 
of drug users and families facing the threat of drug-related 
intimidation.
7 Develop health and social interventions, based on an 
inclusion-health approach to target people who are 
homeless and in addiction.
8 Ensure in-reach supports and pathways to access to 
treatment for homeless, Traveller, and new communities are 
available.
9 Increase the number of residential treatment beds for those 
stabilising, detoxing, and/or seeking drug-free services.
10 Reduce the number of lives lost through overdose by 
opening a pilot medically supervised injecting facility in 
Dublin city.
Drug and alcohol task forces
Finally, underpinning the NDS and its delivery, there is ongoing 
commitment to support the work of the drug and alcohol task 
forces in identifying local need in communities and supporting 
targeted initiatives.
Concluding comment
Overall, the new Programme for Government indicates an 
ongoing commitment to a health-led approach to meet the 
needs of people who use drugs, undertaking a similar set of 
actions to those within the NDS, and to be delivered under 
existing structures. The current strategic action plan expires at 
the end of 2020 but the new Programme for Government would 
indicate that any new version for 2021 and onwards will be closely 
aligned with its predecessor.
Lucy Dillon
1 Fianna Fáil, Fine Gael and the Green Party (2020) Programme 
for Government: our shared future. Dublin: Department of the 
Taoiseach. https://www.drugsandalcohol.ie/32212/
2 Department of Health (2017) Reducing Harm, Supporting 
Recovery: a health-led response to drug and alcohol use in 
Ireland 2017–2025. Dublin: Department of Health.  
https://www.drugsandalcohol.ie/27603/
3 Department of Health (2020) Sharing the Vision: a mental health 
policy for everyone. Dublin: Government of Ireland.  
https://www.drugsandalcohol.ie/32228/
4 See articles in this issue of Drugnet Ireland on Ireland’s response 
to Covid-19 for people who use drugs.
5 Health Products Regulatory Authority (2017) Cannabis for medical 
use: a scientific review. Dublin: Department of Health.  
http://www.drugsandalcohol.ie/26784/
6 Misuse of Drugs (Amendment) Bill 2019 sponsored by John Curran 
TD. Further information available at:  
https://www.oireachtas.ie/en/bills/bill/2019/97/
Programme for Government   
continued
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POLICY AND LEGISLATION 
Sharing the Vision: a 
mental health policy 
for everyone
A new national mental health policy was published in June, 
Sharing the Vision: a mental health policy for everyone.1 It 
succeeds A Vision for Change (AVFC), which has guided policy 
in the area since 2006. Sharing the Vision is described as a 
‘refreshed policy’ in the foreword to the document by Minister 
for Mental Health and Older People Jim Daly TD. It carries 
forward elements of AVFC deemed to be of ongoing relevance 
but also includes many new elements based on the findings of a 
process of research and consultation underway since 2017. The 
new policy is described as being one that ‘focuses very strongly 
on developing a broad-based, whole-system mental health 
policy for all of the population that aligns closely with the main 
provisions of Sláintecare’ (p. 13).
Substance use and mental health
Sharing the Vision recognises people who use drugs as a 
group for which tailored or additional work may be required 
to promote positive mental health and to build resilience. It is 
consistent with the national drugs strategy, Reducing Harm, 
Supporting Recovery, in recognising the ongoing challenges 
faced in addressing the needs of people with a dual diagnosis, 
that is, those who experience mental health problems alongside 
substance (drug and alcohol) misuse problems. Sharing the 
Vision removes the requirement in AVFC for mental health 
workers to establish that a mental health difficulty is ‘primary’ 
for an individual to access the support of a mental health team 
(p. 53).
However, the policy also acknowledges that being able to 
access ‘primary care addiction services and existing mental 
health supports when there is a co-existing mental health/
addiction problem remains complicated’ (p. 53). It outlines and 
supports the approaches to meeting the needs of those with 
a dual diagnosis, as laid out in both the AVFC and Reducing 
Harm, Supporting Recovery. This includes the use of specialist 
multidisciplinary teams with clear pathways in and out of their 
service.
Unlike AVFC, Sharing the Vision includes an implementation 
roadmap with outcome indicators and allocates responsibility 
for delivery of the policy’s set of recommendations to relevant 
lead agencies. Improved delivery of services to meet the needs 
of those with a dual diagnosis are specifically addressed in 
this implementation map, where it is stated that ‘dedicated 
community-based Addiction Service Teams should be 
developed/enhanced with psychiatry input, as required, and 
improved access to mental health supports in the community 
should be provided to individuals with co-existing low-
level mental health and addiction problems’ (p. 59). Those 
responsible for delivering on this action are primary care, the 
Health Service Executive, and the Department of Health via the 
local drug task forces (p. 99).
Lucy Dillon
1 Department of Health (2020) Sharing the Vision: a mental health 
policy for everyone. Dublin: Government of Ireland.  
https://www.drugsandalcohol.ie/32228/
2 Department of Health (2006) A Vision for Change: report of the 
Expert Group on Mental Health Policy. Dublin: Government of 
Ireland. https://www.drugsandalcohol.ie/6154/
3 Department of Health (2017) Reducing Harm, Supporting 
Recovery: a health-led response to drug and alcohol use in 
Ireland 2017–2025. Dublin: Department of Health.  
https://www.drugsandalcohol.ie/27603/
Children’s Bail 
Supervision Scheme 
evaluation
In December 2019, Minister Katherine Zappone launched the 
Evaluation of the Bail Supervision Scheme (BSS) for Children 
report.1 The evaluation, commissioned by the Department 
of Children and Youth Affairs (DCYA), was carried out by the 
Research Evidence into Policy Programmes and Practice 
(REPPP) team from the School of Law in the University of 
Limerick. The overall aim of the evaluation was to examine 
behavioural change outcomes and processes that contributed 
to those outcomes between May 2017 and June 2018. DCYA 
commissioned the social justice charity Extern to deliver the 
‘pilot’ BSS intervention to children deemed at high risk of being 
detained in a prison in Dublin (p. 9).
What is the Bail Supervision Scheme? 
Bail supervision has mainly been used to increase bail 
compliance in youth. It can result in reduced reoffending and 
in consequence a reduced demand for detaining youth during 
the remand period. In Ireland, DCYA established BSS to give 
courts another option for children at risk of being denied bail. 
In addition, in contrast to other jurisdictions, the view in Ireland 
is that the remand period is a time where behavioural change 
can occur. BSS applies the evidence-based multisystemic 
therapy (MST) model as part of routine court processes, such 
as supports provided by the Courts Service, Young Persons 
Probation (YPP), and An Garda Síochána (AGS) (p. 9).
Multisystemic therapy 
MST is an intensive family-based intervention that aims to 
enable change by ensuring that young people remain at home, 
in education, training or working, and are not arrested for new 
charges (p. 12). The main objective is to help move the young 
person towards prosocial activities and peers. The MST model 
also enhances family functionality and support networks and 
enables caregivers to develop skills considered vital to allowing 
them to generalise learning and manage issues that may arise 
in the future. The intervention is implemented in the home 
and caregivers are given support 24/7 for a period of between 
three and five months (p. 12)
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Eligibility requirements
To ensure that BSS targeted young people of highest risk, 
referrals initially were made by Oberstown Children Detention 
Campus and later on by Court 55 (Children’s Court). Eligible 
young people had to meet specific requirements:
• The scheme was mainly confined to the catchment area of 
within 20 miles of Children Court in Dublin.
• Those eligible were aged between 12 and 17 years (inclusive), 
with a minimum of three months prior to their 18th 
birthday.
• Those eligible must be living with an appropriate adult or 
caregiver for the duration of the scheme.
Offers to participate in the scheme occurred at the second 
court appearance when referred by Oberstown and at the 
first court appearance when referred by Court 55. Because 
MST occurred during pretrial court processes, the BSS team 
engaged with statutory agencies (AGS, Oberstown, Tusla, 
YPP, Courts Service) and non-statutory agencies (defence 
and prosecution legal teams, local agencies, e.g. educational 
establishments, youth services, community groups, drug 
counselling services, and local sports groups).
Children’s Bail Supervision 
Scheme   continued
Key themes Action needed
Did the BSS work? • The reduction of offending for young people enrolled on BSS was almost twice that of the control 
group.
• There was evidence of improved adherence to bail conditions.
• 85% of young people who completed BSS with a planned exit attracted a non-custodial option at 
their sentencing hearing.
How did the BSS work? • 31 young people were referred, 20 were enrolled, and 13 had a planned exit from BSS.
Why did the BSS work? • Strong governance, advocates and ‘good news stories’ laid the foundations for buy-in and 
interagency collaboration.
• Governance was flexible, effective, and efficient.
Implementing MST nested within BSS
• MST was implemented with fidelity.
• MST analytical model was described as a basic model that afforded the flexibility to adapt to the 
individual family’s needs.
• BSS team skills, strong teamwork, and problem solving together with external MST input 
contributed to successful outcomes.
• Family engagement in BSS was vital to obtaining positive outcomes.
Challenges in adapting the MST model to fit BSS requirements
• BSS requirement to report breaches in bail compliance hampered family engagement in the 
scheme.
• Perceptions of inadequate treatment duration by caregivers and frontline professionals existed. 
However, these perceptions were countered by the statistical data, indicating little or no further 
benefit from extending planned scheme duration.
• MST eligibility criteria effectively excluded those living in residential care, those outside the 
acceptable age range, and those presenting with complex mental health needs.
Source: Adapted from Naughton et al. (2020, p. 4)
Table 1: Key findings from BSS evaluation
Evaluation methodology
The evaluation was centred on contribution analysis, which 
is a theory of change that involves a six-step rigorous and 
systematic process. This approach can produce credible 
evidence showing that behaviour outcomes can be attributed 
to an intervention. A quasi-experimental design was applied 
and allowed for comparisons to be made between BSS 
participants and a ‘naturally occurring’ control group, 
consisting of youth remanded to custody from areas outside 
the catchment area (p. 16). 
Research questions
Three research questions were addressed:
1 Did the BSS work? More specifically, did the BSS contribute 
to changes in the young person’s behaviour including 
reduced reoffending and adherence to bail conditions?
2 How did the BSS work? More specifically, how many young 
people were referred to, enrolled on and completed the 
BSS during the evaluation period, and what were the factors 
that facilitated or acted as a barrier for referrals?
3 Why did the BSS work? More specifically, how did the BSS 
processes facilitate or act as a barrier to obtaining the 
observed outcomes? (p. 16).
Findings
The evaluation found that offending behaviours were reduced, 
young people had greater compliance with their bail conditions, 
and custodial sanctions were reduced. A summary of the key 
findings is presented in Table 1.
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Key themes Action needed
Did the BSS work? • The reduction of offending for young people enrolled on BSS was almost twice that of the control 
group.
• There was evidence of improved adherence to bail conditions.
• 85% of young people who completed BSS with a planned exit attracted a non-custodial option at 
their sentencing hearing.
How did the BSS work? • 31 young people were referred, 20 were enrolled, and 13 had a planned exit from BSS.
Why did the BSS work? • Strong governance, advocates and ‘good news stories’ laid the foundations for buy-in and 
interagency collaboration.
• Governance was flexible, effective, and efficient.
Implementing MST nested within BSS
• MST was implemented with fidelity.
• MST analytical model was described as a basic model that afforded the flexibility to adapt to the 
individual family’s needs.
• BSS team skills, strong teamwork, and problem solving together with external MST input 
contributed to successful outcomes.
• Family engagement in BSS was vital to obtaining positive outcomes.
Challenges in adapting the MST model to fit BSS requirements
• BSS requirement to report breaches in bail compliance hampered family engagement in the 
scheme.
• Perceptions of inadequate treatment duration by caregivers and frontline professionals existed. 
However, these perceptions were countered by the statistical data, indicating little or no further 
benefit from extending planned scheme duration.
• MST eligibility criteria effectively excluded those living in residential care, those outside the 
acceptable age range, and those presenting with complex mental health needs.
Policing with trust
In July 2020, the Ana Liffey Drug Project published a report 
on the proceedings of the Policing in Changing Policy 
Environments event, held at Dublin Castle in June 2019.1 Forty 
national and international experts came together with the aim 
of sharing knowledge and understanding as well as exploring 
challenges and experiences in the areas of law enforcement 
and public health. The Chatham House Rule was applied 
to the event and to the final report. The event consisted of 
two sessions: the morning focused on providing information 
(presentations and discussions), while the afternoon involved 
interaction (plenary sessions and facilitated working groups).
Session 1
The topics addressed during session 1 covered a range of 
themes.
Theme 1: Role of the police
Delegates believed that the role of the police has evolved. 
Traditionally, policing has focused on detecting and prosecuting 
crime. However, more and more they respond to a wide 
range of social issues. For example, cases that centre on harm 
account for 80% of their workload. A possible explanation put 
forward is that An Garda Síochána is the only ‘first responder’ 
service available that can respond to a broad range of issues 
24/7 (p. 7).
Theme 2: Public health and policing
Delegates acknowledged that public health and law 
enforcement overlapped. Many who experience problems 
with mental health, behaviour, or substance use may not 
receive or have access to suitable services. In consequence, 
these individuals may come into contact with the law or may 
be excluded, or may experience higher levels of adversity. It 
was noted that interventions can have negative and positive 
consequences. For example, there can be increased trauma 
for individuals instead of determining how challenges brought 
them into contact with the law in the first place. Principles 
that were viewed as important to community safety and first-
response settings included using person-centred approaches, 
aimed at decreasing crime, stigmatisation, and traumatisation. 
These should be applied in the community, courts, and prison 
systems.
Theme 3: Need for meaningful partnerships
Meaningful partnerships that centred on ‘joint commitments, a 
shared vision and a shared understanding of goals’ (p. 8) were 
considered the most appropriate way to target community 
safety issues. The role carried out by police was acknowledged 
along with the challenges that arise in balancing interventions 
that provide support, while at the same time ensuring 
that individuals are accountable for their actions from the 
perspective of detecting and prosecuting crime. It was also 
acknowledged that establishing ‘a working multi-agency system 
takes time, commitment, flexibility, compromise, and good 
communication’ (p. 9).
Theme 4: Structural issues
The final theme that emerged centred on international 
and domestic structural issues that may act as a barrier 
to developing person-centred policy. One delegate noted 
that ‘drug policies in most countries of the world are not 
contributing to public health’ (p. 11). While the individual was 
deemed to be at the centre of any response, addressing drug 
use punitively via law enforcement has not been successful and 
often resulted in more harm to those that are disadvantaged. 
Despite this, drug policies globally have centred on a coercive 
approach. Moreover, the illicit drug market was identified as 
an area that created additional harms. Delegates noted that in 
order to focus on public health, the underlying assumptions 
that drug policies are centred on – namely, that ‘criminalisation 
is necessary, that (outside legitimate uses) a drug free world is 
possible or desirable’ (p. 11) – need to be critically examined 
and questioned. Other issues identified at a domestic level 
included structural challenges in service delivery; structural 
barriers that could restrict genuine partnership; and 
personality-led innovations. Attempts to overcome these issues 
depended on appropriate mandates being in place along with 
a commitment and shared understanding of how partnerships 
work.
Issues identified
Public drug use
Drug-related deaths
Sex work
Domestic violence
Public begging
Drug dealing, particularly in the context of treatment centres
Young offenders, particularly in the context of life chances
Drug-related intimidation
Mental health, particularly in the context of dual diagnosis
Organised crime, particularly in the context of the illicit drug 
market
Table 1: Relevant cross-cutting scenarios or issues for Ireland
Children’s Bail Supervision 
Scheme   continued
Conclusion
Minister Zappone acknowledged the recognition that BSS 
had received within Ireland and internationally and thanked 
all agencies, statutory and non-statutory bodies, that were 
involved. Following the success of BSS in Dublin, in June 
2020, the Minister provided funding to expand and extend the 
scheme to courts in Cork and Limerick.2 
Ciara H Guiney
1 Naughton C, Redmond S and Coonan B (2019) Evaluation of the 
Bail Supervision Scheme for Children (pilot scheme). Dublin: 
Department of Children and Youth Affairs.  
https://www.drugsandalcohol.ie/31491/ 
2 Department of Children, Equality, Disability, Integration and Youth 
(2020) Press release: Minister Zappone extends successful Bail 
Supervision Scheme. Available online at:  
https://www.gov.ie/en/press-release/c0fb7-minister-zappone-
extends-successful-bail-supervision-scheme/
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Questions
What is the scenario?
Who are the key stakeholders?
What is their purpose?
What are the desired outcomes in this scenario (for the 
different stakeholders)?
What actions do they need to take to achieve these 
outcomes?
Where could there be potential conflicts and potential 
opportunities for joint action between the stakeholders?
Table 2: Questions addressed by working groups
Session 2
Session 2 consisted of plenary sessions and interactive 
workshops. The aim of this session was to provide delegates 
with an opportunity to investigate the difficulties of addressing 
issues of community safety by considering the challenges 
that communities are faced with. The session started with 
an overview of the Irish context and included participants 
reflecting on practical experience observations and 
government policy. Several areas were highlighted, including 
Ireland’s commitment to using a health-led and person-
centred approach to drug use; ongoing development of policing 
services; and international attention for recent progressive 
policy developments. Table 1 illustrates the main issues 
identified.
With the aim of increasing understanding, motivations, roles, 
and potential intervention opportunities, four of the issues/
scenarios identified in Table 1 were examined in more detail in 
breakout working groups (n=4). The main questions utilised to 
explore these issues are shown in Table 2.
Group 1: Organised crime
In the area of organised crime, more specifically the illicit drug 
market, delegates identified the key stakeholders involved. 
For example, the individual buying and taking drugs; local 
drug supplier; family of drug user; police; government; and 
community bodies. It was noted that while commonalities exist 
between stakeholders, for example community safety, there 
may also be competing objectives in terms of what should be 
prioritised.
Group 2: Mental health
The emphasis here was on dual diagnosis, where individuals 
presented with substance use disorder along with another 
mental health problem. The key stakeholders identified 
included the individual experiencing the dual diagnosis; their 
family or carers; health and social stakeholders involved in 
their care; and first responders to a crisis, which is often law 
enforcement officers. Delegates recognised that different roles 
occurred within these groups along with alternative beliefs 
regarding treatment. However, they believed that ultimately 
interventions should be centred on the needs and human 
rights of the individual. Challenges identified included inflexible 
current structures and ensuring consistent case management.
Group 3: Drug-related intimidation
Using a street-level intimidation scenario, delegates identified 
several stakeholders. For example, individuals with drug debt 
and their families; the dealer; other third parties, such as a 
middle person; and the police. It was mainly believed that 
stakeholders had diverging or overlapping motives. Delegates 
noted the complexity of drug-related intimidation and that 
roles are not always clear-cut. The main outcome desired 
was that all players – the person owing the debt, the dealer, 
and anyone else involved – leave the drug market. However, 
because of the illicit nature of the drug market, there is no 
legal remedy or way to resolve disputes that arise, which has 
resulted in intimidation being the only route to debt recovery. 
While this was not expected to change, delegates believed that 
interventions existed that could be helpful.
Group 4: Young offenders and life chances
The final group examined young offenders, specifically 
challenges in relation to repeat offending. The key stakeholders 
identified included the young person; their family or carer; 
their school; and broader community. Consistent with issues 
identified by delegates in other groups, it was noted that roles 
and motives differed within stakeholder groups. Issues were 
deemed complex; however, opportunities were also noted. For 
example, the importance of credible role models was discussed 
along with service orientation, where it was acknowledged 
that a ‘one size fits all’ (p. 16) approach was not likely to work. 
It was also noted that youth engagement was often centred on 
negative behaviour, ‘what the person wasn’t doing, or wasn’t 
doing right’ (p. 17). Focusing on relationships and building strong 
networks away from their education/social support system was 
deemed more effective.
While these four issues/scenarios were not the same, they did 
have themes in common: issues in community safety, public 
health, and law enforcement consistently emerged.
Conclusion
Concluding reflections reiterated and reinforced the themes 
that emerged throughout the day. In particular, it was 
noted that openness to partnership was necessary. It was 
acknowledged that an already recognised common goal for 
many agencies was working together. However, alongside State 
bodies and non-governmental organisations it is vital that the 
community participate in community safety. Interventions 
put forward need to be tailored to the needs of the individual 
using a human rights approach characterised by trust and 
commitment by stakeholders. For the system to work, it must 
be believed that improvements will occur in community safety 
and policing. For this to occur change is inevitable. The full 
implementation of recommendations by the Commission on 
the Future of Policing in Ireland are a vital step in initiating 
change along with stakeholder willingness to build meaningful 
partnerships.2
Ciara H Guiney
1 Ana Liffey Drug Project (2020) Policing with trust. Dublin: Ana Liffey 
Drug Project. https://www.drugsandalcohol.ie/32223/
2 Commission on the Future of Policing in Ireland (2018) The future 
of policing in Ireland. Dublin: Commission on the Future of 
Policing in Ireland. Available online at:  
http://www.policereform.ie/en/POLREF/Pages/PB18000006
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COVID-19
LSE report on Irish 
response to Covid-19
In July 2020, the London School of Economics and Political 
Science (LSE) published a report on Ireland’s response to 
Covid-19 in relation to people who are homeless and use drugs, 
entitled Saving lives in the time of COVID-19: case study of 
harm reduction, homelessness and drug use in Dublin, Ireland.1 
The report is a policy briefing that outlines the policy changes 
made in Ireland to harm reduction services in response to 
Covid-19. It argues that lives within the target group were saved 
as a result of these changes and that the policy changes should 
be maintained in the post-Covid era.
Housing response
People experiencing homelessness were identified as a 
vulnerable group when the Covid-19 pandemic reached Dublin. 
Protocols for identification and immediate testing for people in 
this group were developed and implemented. Accommodation 
was provided to allow suspected and positive cases to isolate, 
as well as those deemed vulnerable due to age or medical 
condition. The report argues that this resulted in much lower 
than expected Covid-19 infection and mortality rates. Seven 
hundred and fifty clients were tested, of whom 63 tested 
positive. One person died. Dr Austin Carroll is one author of 
the report and the Covid-19 clinical lead for homelessness 
in Dublin. His team carried out projections on the number 
of expected fatalities using a data projection programme 
developed in the United Kingdom and adjusted for Ireland.2 It 
indicates that the policy response, combined with the quick 
and dedicated response of services and their staff, contributed 
to a much lower than expected mortality figure (see Figure 1).
Drug policy changes
In addition to meeting the testing and housing needs of this 
group, policy changes were made that improved access to 
three harm reduction interventions for those who were using 
drugs. These were opiate substitution therapy (OST); naloxone; 
and benzodiazepine (BZD) maintenance, which are outlined 
below.
Opiate substitution therapy: There were two key changes in 
the area of OST – one related to accessing a programme, the 
other to the dispensing of methadone. National contingency 
guidelines were issued, allowing for reduced waiting times and 
removal of caps on recruitment to OST at the two clinics that 
provide treatment for this group (National Drug Treatment 
Centre and GMQ Medical).3 These new guidelines resulted in 
the waiting times for treatment at one service provider (GMQ 
Medical) being reduced from 12–14 weeks to 2–3 days. Access 
was further improved by other treatment clinics agreeing 
to take on homeless patients who were resident in their 
catchment areas. Supervision guidelines were also amended. 
Staff at relevant agencies were allowed to collect clients’ OST 
medications and deliver them to the client’s accommodation. 
This supported clients who were self-isolating.
Naloxone: Access pathways to the opioid antagonist naloxone 
were relaxed in response to the Covid-19 crisis through 
the national contingency guidelines.3 The new guidelines 
recommend that everyone in receipt of OST should be offered 
and encouraged to take a supply of naloxone. It was to be 
administered by a person trained in its use and the injectable 
product used instead of the intranasal product. Access 
was then extended to those most at risk of overdose in the 
evolving situation, and packs were distributed to those using 
a needle and syringe programme by Ana Liffey Drug Project. 
The requirement for a prescription to be issued by a general 
practitioner to the client by name could be met retrospectively.
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Figure 1: Mortality from Covid-19 homeless sector
Source: Carroll et al. (2020), p. 4
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Benzodiazepine maintenance: In Ireland, the focus of national 
guidelines for the treatment of BZD use is detoxification, not 
maintenance.4 However, in response to the pandemic, national 
contingency guidelines were published, which recommended 
that isolating clients of treatment services could be offered 
up to 30 mg daily to prevent withdrawals for the period of 
isolation. O’Carroll et al. note that this was extended by those 
working in the homeless sector to those who were shielding (p. 
7) and to all those on OST with established BZD dependency in 
one service (GMQ Medical). As with OST medications, service 
providers were able to deliver medications to clients in their 
accommodation.
Call to sustain the changes
In their conclusion, the authors note that the key element 
of the first two of these policy changes (the removal of 
barriers to rapid access to OST and naloxone) resulted in the 
implementation of existing national policy, which they argue 
raises the question as to why barriers existed prior to the 
pandemic. They also argue that prior to and independent of 
Covid-19 there was a ‘strong public health argument for having 
no waiting lists for OST and improved naloxone distribution to 
PWUD [people who use drugs]’ (p. 9).
The authors describe the pandemic as having ‘acted as a 
catalyst for changes in the delivery of harm reduction measures 
to homeless PWUD’ (p. 10). They recommend that ‘practices 
continue to deliver on OST and naloxone policy objectives and 
that policy makers review the evidence on BZD maintenance 
treatment’ (p. 10). In conclusion, they view the Covid-19 
experience as a ‘potentially important milestone in the 
development of national drug policies’ (p. 10).
Conclusion
As mentioned, the report’s authors recommend that the policy 
changes made in response to Covid-19 be maintained in the 
post-Covid era. While there is no reference to BZD use, the 
June 2020 Programme for Government: our shared future5 
offers a commitment to elements of the other two policy 
changes:
• To retain the specific actions taken to support increased 
and improved access to opioid substitution services during 
Covid-19, so that pre-Covid waiting times in accessing these 
services are reduced.
• To support the rollout of access to and training in opioid 
antidotes.
Lucy Dillon
1 O’Carroll A, Duffin T and Collins J (2020) Saving lives in the time of 
COVID-19: case study of harm reduction, homelessness and drug 
use in Dublin, Ireland. London: London School of Economics and 
Political Science. https://www.drugsandalcohol.ie/32291/
2 The data projection programme was devised for the homeless 
population in London by Prof Al Story and Prof Andrew Hayward 
of University College London.
3 Health Service Executive (HSE) National Social Inclusion Office 
(2020) Guidance on contingency planning for people who use 
drugs and COVID-19. Dublin: HSE.  
https://www.drugsandalcohol.ie/31804/
4 Health Service Executive (2016) Clinical guidelines for opioid 
substitution therapy. Dublin: HSE.  
https://www.drugsandalcohol.ie/26573/
5 Fianna Fáil, Fine Gael and the Green Party (2020) Programme 
for Government: our shared future. Dublin: Department of the 
Taoiseach. https://www.drugsandalcohol.ie/32212/
LSE report   continued
Covid-19 and 
community alcohol 
detoxification
Introduction
In response to the Covid-19 pandemic, the Irish Government 
implemented unprecedented measures restricting the 
movements, activities, and social contacts of the population. 
These restrictions, which came into effect on 12 March 2020, 
have greatly disrupted people’s lives, with many unable to 
pursue their usual occupational, educational, social, and 
recreational goals, or to access healthcare as before. Health 
professionals have raised concerns about the possible public 
health impacts, including changes in levels and patterns of 
alcohol use associated with increased stress and anxiety, as 
well as social isolation, loneliness, and boredom.1,2,3 These 
predictions are supported by data from a recent Central 
Statistics Office (CSO) survey, in which 22.2% of respondents 
reported increasing their alcohol consumption since the 
introduction of restrictions.4
Alcohol-dependent persons and those who may develop 
harmful patterns of alcohol use are at risk under the restrictive 
conditions.1,3 Persons already in treatment or recovery risk 
relapse as a result of increased stress and decreased access 
to the usual supports, such as Alcoholics Anonymous.2,3 
With physical distancing restrictions and pressures on health 
services due to Covid-19, people may experience a delay in 
accessing care or may delay contact with services due to 
fear, with potential longer-term health impacts and increased 
pressure on services.
While some persons with alcohol dependency will require 
inpatient or other residential detoxification, others can safely 
detoxify at home with appropriate supervision and support.5,6 
The Health Service Executive (HSE), in line with 2011 National 
Institute for Health and Clinical Excellence (NICE) principles, 
issued guidelines recommending community-based assisted 
withdrawal where possible for persons presenting with alcohol 
withdrawal symptoms during the crisis.7,8 Community alcohol 
detoxification (CAD) programmes aim to provide safe and 
controlled withdrawal in the community for persons who are 
alcohol dependent.9,10 For persons with mild-to-moderate 
alcohol dependency, the community is considered a safe, 
successful, and cost-effective setting in which to reduce 
alcohol use and associated harms.5,6
Covid-19 has challenged treatment providers to ensure 
continuity of services in an environment that is safe for service 
users and the staff who support them. Doing so has required 
timely adaptation and innovation on behalf of providers. The 
impact of Covid-19 on a CAD programme in the northeast of 
Ireland is described below.
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Turas CAD programme
Based in Dundalk, Turas (meaning journey) has been providing 
a CAD programme since 2011. The CAD process includes 
motivational support, medical detoxification, relapse 
prevention, and counselling, followed by SMART Recovery 
for those who wish to avail of it. A key feature of CAD is the 
provision of individually tailored programmes with wraparound 
supports, which are provided while enabling the individual 
to maintain education, work, and family responsibilities. 
Another key feature is that CAD requires a support person, 
usually a family member or friend, whose role is to support 
the detoxification client through withdrawal at home. Access 
to the programme starts with a general practitioner referral 
and acceptance is based on medical assessment. Turas 
CAD is provided by two project workers; a clinical manager; 
a counsellor; and a specialist detoxification nurse, who 
manages the programme with general practitioner oversight. 
Approximately 40 persons complete the CAD programme with 
medical detoxification annually.
Impact of Covid-19 on service provision
Like other frontline providers, Turas has had to reconfigure 
itself in order to continue delivering its services, including CAD, 
throughout the crisis. Manager Nicki Jordan explained that 
following the closure of the offices on 12 March, the aim was to 
provide an effective and successful programme remotely, with 
staff and client safety to the fore. Face-to-face sessions were 
replaced with telephone, video, ‘walk-and-talk’, and ‘car-
to-car’ meetings, where possible. Physical distancing meant 
group-based interventions could not be continued; instead, 
meetings were held using video conferencing. With distancing, 
it was not possible for CAD nurse Patricia Kelly to carry out 
baseline observations, breathalyser checks, haematology 
screening, and BMI checks as before. Instead, additional 
assessment tools were incorporated and carried out by 
telephone where relevant, with greater reliance on the client’s 
own general practitioner to ascertain the client’s physical 
health needs.
With reduced access to the usual social outlets and 
distractions, loneliness and boredom have increased among 
clients. In some cases, mental health issues have emerged 
or intensified. In response, the programme is focusing more 
intensely on the client’s self-care and on structuring, planning, 
and relaxation. Daily online meditation has been added to 
the programme, and resources have been updated to include 
distraction exercises and videos on topics such as relapse 
prevention and anxiety management. Where possible, clients 
are linked to online peer-to-peer support meetings. Kelly 
explained that some clients have little or no social contact 
outside of CAD staff and that these clients expressed genuine 
relief that the service remained open, albeit remotely. Staff 
have been proactive in contacting past clients at risk of relapse 
and placed a notice in the newspaper to communicate that 
services are available. A significant challenge, however, has 
been the reduced access to other treatment and aftercare 
services, mental health services, and beds in residential 
services. Also, in some instances, clients have refused to attend 
for emergency medical treatment due to fear of Covid-19.
Over the period, the number of clients remained stable or 
increased across Turas programmes. From a staff perspective, 
working in a more diverse and flexible way has been key to 
maintaining the service and client engagement. For staff, 
Covid-19 protocols, extended operational hours, and more 
frequent team meetings have meant that self-care has been 
more important than ever.
There is a lack of published research to inform CAD via remote 
delivery. Staff plan to undertake an evaluation to determine 
which adaptations and processes have been effective and for 
whom. While teleworking has worked well with some clients, it 
is less suitable for others, such as those without the necessary 
technologies and some clients for whom English is not a first 
language. Going forward, Turas is likely to provide a blended 
approach for clients to complement existing services. Although 
this will not suit everyone, it will work effectively for some, 
including clients who do not need face-to-face contact or who 
experience transport barriers in accessing the service.
Conclusion
Measures to control Covid-19 have implications for public 
health, the provision of services, and targeting of support 
within public health guidelines. SARS-CoV-2 continues to 
circulate, while the full impact on alcohol use, alcohol-related 
harm, and service delivery is not yet known. Research is 
needed to address the impact of Covid-19 on those at risk of 
harmful drinking and those already dependent. It should also 
aim to identify best practice in service delivery through remote 
and blended approaches.
Cathy Kelleher
1 Clay JM and Parker MO (2020) Alcohol use and misuse during 
the COVID-19 pandemic: a potential public health crisis? Lancet 
Public Health, 5(5): e259.
2 Columb D, Hussain R and O’Gara C (2020) Addiction psychiatry 
and COVID-19: impact on patients and service provision. Ir J 
Psychol Med, 37(3): 164–168. 
https://www.drugsandalcohol.ie/32062/
3 Drinking alone: COVID-19, lockdown, and alcohol-related harm 
[editorial] (2020) Lancet Gastroenterol Hepatol, 5(7): 625.
4 Central Statistics Office (CSO) (2020) Social impact of COVID-19 
survey April 2020. Cork: CSO.  
https://www.drugsandalcohol.ie/31956/
5 Davis C (2018) Home detox – supporting patients to overcome 
alcohol addiction. Aust Prescr, 41(6): 180–182.
6 Nadkarni A, Endsley P, Bhatia U, et al. (2017) Community 
detoxification for alcohol dependence: a systematic review.  
Drug Alcohol Rev, 36(3): 389–399.
7 Health Service Executive (2020) Guidance on contingency 
planning for people who use drugs and COVID-19. Dublin: Health 
Service Executive. https://www.drugsandalcohol.ie/31804/
8 National Institute for Health and Clinical Excellence (NICE) (2011) 
Alcohol-use disorders: diagnosis, assessment and management 
of harmful drinking and alcohol dependence. National Clinical 
Practice Guideline 115. London: NICE.  
https://www.drugsandalcohol.ie/14743/
9 Mannix M (2006) Drug and alcohol detoxification services: a needs 
assessment for Cork and Kerry 2015. Cork: Department of Public 
Health and HSE South (Cork and Kerry).  
https://www.drugsandalcohol.ie/6047/
10 Substance Abuse and Mental Health Services Administration 
(SAMHSA) (2006) Detoxification and substance abuse treatment. 
A Treatment Improvement Protocol (TIP) Series, No. 45. Rockville, 
MD: Substance Abuse and Mental Health Services Administration. 
https://www.drugsandalcohol.ie/14171/
Alcohol detoxification   continued
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drug users during 
Covid-19: the Irish 
experience
The Covid-19 pandemic presents a major challenge to 
healthcare services and the provision of care. A commentary 
on the Irish experience of challenges faced by people who 
use opioids (PWUO) and the service providers working with 
this vulnerable population was published in Heroin Addiction 
and Related Clinical Problems.1 The authors also describe and 
discuss the evidence guiding the measures implemented to 
reduce the risks associated with Covid-19 to Irish opioid agonist 
treatment (OAT) services.
Various national and international bodies have highlighted 
additional dangers faced by PWUO and produced guidelines 
for drug treatment and harm reduction practitioners. To this 
end, the Health Service Executive (HSE) published guidelines for 
general practitioners and pharmacies providing OAT services to 
those at greatest risk at this time.2
Changes to OAT services
Many Irish OAT services have adapted treatment delivery to 
reduce the emerging Covid-19 risks. These changes include:
• Restructuring OAT assessment and induction procedures to 
allow easy access to treatment and to avoid waiting lists
• Fast-tracking of patients requiring isolation to OAT
• Home delivery of OAT and other medications
• Reducing OAT supervision requirements
• Adapting virtual patient care and telemedicine
• Reducing/postponing non-essential services, including 
drug and blood-borne virus (BBV) screening and hepatitis  
C treatment
• Providing remote counselling support
• Providing virtual multidisciplinary team meetings
• Increasing access to overdose prevention training and 
naloxone
• Providing targeted interventions for homeless and more 
vulnerable patients, including increased access to more 
suitable accommodation and supports
• Reducing the prison population.
In common with all health services, reducing the need for face-
to-face interactions is advised. By reducing this requirement, 
the potential risk of transmission is minimised, thus protecting 
staff and patients.
Risk of drug overdose
Reduced supervision may increase street diversion and drug 
overdose; therefore, risk assessment and individualisation 
of care are critical. Providing information on OAT-related 
dangers and safe storage may reduce these risks. Irish 
overdose prevention and naloxone programmes have also 
been expanded to lessen the risks. Overdose education and 
naloxone programmes have been shown to reduce fatal opioid-
related overdose.3 Overdose prevention programmes have 
conventionally recommended the use of cardiopulmonary 
resuscitation (CPR) and the administration of intranasal or 
intramuscular naloxone. Given the increased risks associated 
with Covid-19, training programmes have now been revised and 
delivered remotely, removing the endorsement of CPR and use 
of intranasal naloxone.
Drug screening
Reducing OAT supervision requirements provides services with 
an opportunity to evaluate the practicality of drug screening 
and to adopt a more evidence-based approach in the post-
Covid future. Currently, there is little published evidence on the 
efficacy of routine drug screening. Indeed, screening schedules 
tend to be philosophical and historical within services.4
Telemedicine and opioid substitution therapy
Irish OAT services have adopted telemedicine to conduct risk 
triaging, assessment, reviews, counselling, and psychosocial 
support. Using telemedicine, OAT services have been able to 
offer patients quicker access to opioid substitution therapy 
(OST) and reduce waiting lists. OST induction is acknowledged 
as a high-risk period for overdose and caution should therefore 
be exercised. Establishing dependence and assessing tolerance 
are critical, as is dosing over the first four days.5
Self-isolation
Given the risk profile of PWUO, many patients attending OAT 
services will be required or recommended to self-isolate. 
This presents difficulties for both service providers and 
patients. Irish OAT services have established a home delivery 
network informed by local resources, geography, and need. 
Staff redeployed from statutory and non-statutory services 
and An Garda Síochána have been engaged in providing risks 
assessments and supports, where necessary.
BBV screening and treatment
OAT services have suspended routine BBV screening, 
vaccinations, and new hepatitis C treatment. In the short 
term this may have little impact but there may be medium-
term to long-term costs for patients. Central to the work of 
OAT services has been the identification and management of 
BBVs. Prior to Covid-19 restrictions, OAT services had been 
engaged in increasing hepatitis C screening and treatment, with 
elimination of hepatitis C infection as their goal. Lack of testing 
and treatment, along with reduced supports and access to 
harm reduction services, may increase rates of reinfection and 
may impact negatively on ‘treatment as prevention’ initiatives.6 
Irish OAT services have effectively used telemedicine for 
hepatitis C treatment, provision of psychological support, and 
other supports.7,8,9
Wider usage of telemedicine
The wider usage of telemedicine has brought about a 
fundamental change in care delivery and work practices. 
While patients have adapted well to these changes, it has 
highlighted the need to have up-to-date phone contact details. 
Provision of phones to those without them is vital to capitalise 
on the benefits of these changes. Telephone consultations 
are adequate for most patients; however, video consultations 
may be more appropriate for patients with greater health and 
psychosocial needs.10
It is worth noting at time of writing that the HSE has not yet 
agreed a common platform for use in telemedicine. However, it 
does not recommend the use of video-conferencing services 
for clinical purposes.
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Remote counselling services and supports
From the onset of Covid restrictions, residential drug treatment 
and aftercare services closed. This afforded the opportunity 
to redeploy staff to provide remote counselling services and 
other supports. At first, patients struggled to adapt to the 
situation but are now increasingly reporting satisfaction with 
this approach.
New models of care
The authors note while it is important to focus on emergency 
efforts to manage, treat, and develop a vaccine to control this 
pandemic, it is also important that new models of delivering 
medical and social care are fully evaluated.11 Models developed 
during this time of crisis may have real benefits for patients and 
the healthcare systems in the future. It is also imperative to 
evaluate any potential negative impacts of these new models 
and work to decrease them.11
Adequate resources for such evaluations should be factored 
into health budgets, as many of these new measures could 
have significant health benefits and cost savings in a post-Covid 
future.
Conclusion
In conclusion, PWUO have greater health and social risks 
that make them more vulnerable during the current Covid-19 
pandemic. OAT services can and have adapted to reduce the 
risks faced by this marginalised population. Measures adopted 
have both immediate and future benefits to this group. Ongoing 
evaluation of such measures is critical, as it can inform how 
health and social care are delivered across the health services. 
Many of these measures will also impact health and social care 
outcomes and potential cost savings in a post-Covid future.
The report authors hope that these positive changes and 
learnings can address some of the social and health inequalities 
experienced by so many.
Opioid drug users   continued Vivion McGuire
1 Crowley D and Cullen W (2020) Caring for opioid drug users during 
the COVID-19 pandemic: a commentary on the Irish experience. 
Heroin Addiction and Related Clinical Problems, Early online. 
https://www.drugsandalcohol.ie/32214/
2 Health Service Executive (2020) Guidance on contingency 
planning for people who use drugs and COVID-19. Dublin: Health 
Service Executive. https://www.drugsandalcohol.ie/31804/
3 Walley AY, Xuan Z, Hackman HH, et al. (2013) Opioid overdose 
rates and implementation of overdose education and nasal 
naloxone distribution in Massachusetts: interrupted time series 
analysis. BMJ, 346(7894): f174.
4 McEachern J, Adye-White L, Priest KC, et al. (2019) Lacking 
evidence for the association between frequent urine drug 
screening and health outcomes of persons on opioid agonist 
therapy. Int J Drug Policy, 64: 30–33.
5 Sordo L, Barrio G, Bravo MJ, et al. (2017) Mortality risk during and 
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the ECHO® telementoring model for the treatment of patients 
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Needle exchange 
provision during 
Covid-19 pandemic
Background and concerns
The current national drugs strategy1 aims to reduce harms 
arising from substance misuse and to reduce the prevalence 
of blood-borne viruses among people who inject drugs (PWID) 
through the expansion of needle exchange. In Ireland, this 
service is delivered in a number of ways, including fixed-site 
locations, such as clinics or community pharmacies, and novel 
interventions, such as Backpacking Outreach programmes.
In Ireland, the Health Service Executive (HSE) has noted 
that just as the sharing of injecting material increases the 
risk of infection with blood-borne viruses, such as HIV and 
viral hepatitis B and C, the sharing of injecting equipment 
contaminated with Covid-19 may also increase the risk of 
infection and play a role in the spread of the virus. In addition, 
the Covid-19 outbreak may present additional risks currently 
not widely recognised. These may include the sharing of 
cannabis joints, cigarettes, vaping or inhalation devices, or  
drug paraphernalia.
With regard to needle exchange provision in Ireland, the 
HSE notes that disruption to the supply of, and access to, 
equipment is likely to occur for a number of reasons. These 
may include staff shortages, service disruption and closure, 
self-isolation, and restrictions placed on free movement.
Recommendations and processes
With these concerns in mind, the HSE has made a number of 
recommendations.2 These include:
• A broader harm reduction approach in the current 
Covid-19 pandemic should be considered by services when 
they deliver interventions.
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• Harm reduction advice should include information on the 
risk of Covid-19 transmission through all forms of intake, 
including sharing of cannabis joints, cigarettes, vaping, and 
injecting equipment.
• Contingency plans should be developed to ensure 
continuity of provision of drug use paraphernalia. Scaling 
up the level of equipment provision for individuals in self-
isolation is likely to be necessary.
• The utilisation and training of additional staff from Section 
39 agencies involved in the provision of care for PWID 
should be considered to deal with staff shortages in 
community healthcare organisation areas. The phone 
number of the harm reduction service should be available 
and circulated widely among the community targeted for 
injecting equipment.
• If an individual is in self-isolation and requires needle 
exchange, requests for equipment should be made by 
phone and amounts and equipment should be prepacked 
and then delivered to the specific location.
Needle exchange   continued • Staff members should ensure that the intended target is in receipt of the package and that the package is not left 
unattended.
• At fixed-site location services, requests should be made by 
phone and equipment should be prepacked and handed 
out at the front door.
• All HSE staff and allied professionals delivering harm 
reduction services and injecting equipment should be 
provided with clear guidelines in relation to minimising 
contact with individuals, dealing with issues over the phone, 
and maintaining personal safety.
Seán Millar
1 Department of Health (2017) Reducing harm, supporting recovery: 
a health-led response to drug and alcohol use in Ireland 
2017–2025. Dublin: Department of Health.  
https://www.drugsandalcohol.ie/27603/
2 Health Service Executive (2020) Needle exchange provision in 
COVID-19 pandemic. Dublin: Health Service Executive.  
https://www.drugsandalcohol.ie/32048
PREVALENCE AND CURRENT SITUATION
Crack cocaine  
use in Ballymun
Crack cocaine has become increasingly problematic for 
some marginalised communities. The recent identification 
of particular sites in Ballymun, Dublin associated with crack 
cocaine use has raised serious concerns of an emerging 
crack cocaine problem in the local area, similar to other 
communities. Despite the increase in levels of usage and 
treatment-seeking for crack cocaine use, there is limited 
national and international research available on the nature and 
extent of its use. Local anecdotal evidence in Ballymun suggests 
that the problem is widespread and having a detrimental impact 
on the health and wellbeing of users, their families, and the 
wider community. While drug issues and related harms are not 
a new phenomenon in this community, this is the first time that 
Ballymun has faced a crack cocaine issue of such proportions. 
In light of these developments, a recent study explored crack 
cocaine use experiences in the Ballymun community with 
a view to informing the establishment of a local policy and 
practice/intervention evidence base for crack cocaine in 
Ballymun.1
Methodology
The research used a qualitative study design, and data were 
collected through 22 semi-structured interviews and four 
focus groups during the period September 2018 to February 
2019. Data collection consisted of individual semi-structured 
interviews with former and current users of crack cocaine, 
family support members, local community representatives, An 
Garda Síochána, and local treatment and rehabilitation service 
providers.
Findings
The main findings are discussed below.
Crack cocaine use and motivations for use
Among current crack users, 17 interviewees were polydrug 
users, and identified the use of heroin, alcohol, benzodiazepines 
and pregabalin along with their use of crack cocaine. The 
most widely used substance alongside crack cocaine was 
methadone. Thirteen (76.5%) of those interviewed were 
prescribed methadone and two (11.8%) had previously been 
prescribed methadone. Interviewees described several reasons 
for their use of crack cocaine. These reasons ranged from being 
introduced to it through their drug-using peer networks to a 
more deliberate decision-making process to help them forget 
about and escape other difficult life issues, and to enhance self-
confidence.
Availability and accessibility
Research participants expressed their concerns in terms of the 
availability and visibility of both crack cocaine usage and dealing; 
the accessibility of crack through aggressive targeting and 
overt dealing; young people’s involvement in the crack cocaine 
market; and the role of environmental factors influencing 
the local crack cocaine market. In particular, the perceived 
increased availability of crack cocaine in the community was also 
identified by local service providers encountering and working 
with individuals who are using crack cocaine; by those engaged 
in broader community work; and by An Garda Síochána. The 
current availability of crack in the community was believed to 
have increased over the previous two years.
Physical and mental health
The two main physical health issues associated with crack 
cocaine use and experienced by interviewees were breathing 
problems and weight loss due to decreased appetite and desire 
to eat. Interviewees described the mental health consequences 
they experienced in connection with their crack cocaine use as 
being far greater than and more consequential than the physical 
health consequences experienced. Interviewees stated that 
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they experienced confusion, depression, paranoia, and anxiety 
while using crack cocaine. They also discussed the self-harm 
and suicidal thoughts they experienced and which they directly 
attributed to their use of crack cocaine. Some interviewees 
described periods of time spent in mental health facilities as a 
direct consequence of the mental health issues they attributed 
to their use of crack cocaine.
Family and community impacts
Family members described being frightened in their homes as 
they experienced aggression and intimidation from their adult 
children. This aggression and intimidation were attributed to 
their adult children’s use of crack cocaine and their seeking of 
money for crack. The stigma associated with the use of cocaine 
was also experienced by family members of those using crack. 
Family members described their difficulty in accepting and 
acknowledging that a family member was using crack cocaine 
as they perceived this substance and its usage to be far worse 
than any other substance.
Community representatives and local service providers 
described the community’s concerns in relation to crack 
cocaine use. Participants described feeling frightened and 
intimidated by gangs, by the visible drug market, and by the 
evident crime and violence in the community. Overall, a sense 
of feeling unsafe within the community was expressed by many 
interviewees and research participants along with a heightened 
sense of risk to personal safety.
Responses and interventions
Service providers described the responses available within 
current service provision along with the prevailing challenges 
encountered in working with and providing a service to 
individuals who are using crack cocaine. Drop-in services, 
outreach – including street work and home visits – advocacy, 
one-to-one key working, and the distribution of food parcels 
were identified as core interventions and responses currently 
provided.
Crack pipe distribution was identified as a key intervention as 
both a tool for engagement and a harm reduction response. 
This intervention was implemented on foot of interagency 
discussions and the agreed need for an interagency approach 
to crack cocaine use in the community. Crack pipes are 
distributed on site in the Ballymun Youth Action Project and by 
the Health Service Executive (HSE) Addiction Service.
Conclusions
In light of the study findings, the report authors made a number 
of recommendations to support local crack cocaine policy 
and practice development. In particular, they recommend 
the establishment of a multiagency working group, including 
community representation, to develop and implement an 
action plan and that prioritisation be given to the following 
actions at both a local and national level:
• Accessible interventions: The lack of accessible crack-
cocaine specific interventions emerged in the research. 
The need for early access to adequate crack cocaine 
services, including the provision of residential respite and 
stabilisation beds, is recommended.
• Mental health: Given the mental health consequences 
experienced by individuals using crack cocaine in this study 
and evidenced in previous studies, improved cooperation 
between drug services and mental health services is 
required. A local strategy responding to the dual diagnosis 
needs of individuals using crack cocaine is recommended.
• Outreach: Due to the chaotic nature of some crack cocaine 
use, the importance of outreach to individuals using crack 
cocaine is reinforced in this research. Building on existing 
local outreach services, the need for a more targeted and 
crack-cocaine specific outreach is recommended. This 
would include out-of-hours outreach and signposting to 
existing services.
• Basic needs: Given the personal adverse consequences 
experienced with crack cocaine use, the provision of 
services and interventions that respond to the physical and 
psychological wellbeing of individuals using crack cocaine, 
thus ensuring that basic needs such as food, light, heat, 
and primary healthcare are being met, is recommended. 
The potential role of contingency management should be 
considered further.
• Accommodation: Housing issues and hostile takeovers 
emerged as a key issue for individuals using crack cocaine. 
Building further on the existing interagency work that has 
taken place with regard to accommodation-related issues is 
recommended.
• Policing: Given the issues of fear, safety, and security 
which emerged in the research along with the increased 
availability of crack cocaine in the community, continued 
cross-agency and community engagement with An Garda 
Síochána is recommended.
Seán Millar
1 O’Reilly L and Mac Cionnaith C (2019) Crack cocaine use in 
Ballymun: an evidence base for interventions. Dublin: Ballymun 
Youth Action Project. https://www.drugsandalcohol.ie/31345/
Crack cocaine use in Ballymun   
continued
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20 Irish drug use findings 
from European  
Men-Who-Have-Sex-
With-Men Internet 
Survey
Most men who have sex with men (MSM) and who use 
recreational drugs do so on a sporadic basis, for specific 
purposes such as partying, socialising, or having sex. However, 
evidence suggests that among MSM who use drugs, there is a 
preference for ‘sex drugs’, including alkyl nitrites (‘poppers’), 
crystal methamphetamine (‘crystal meth’), club drugs (including 
ketamine and ecstasy), and new psychoactive substances.1 Use 
of these drugs is associated with higher-risk sexual behaviours 
and sexually transmitted disease acquisition.2 Little is known 
about the prevalence and determinants of drug use among 
MSM in Ireland. However, the number of HIV diagnoses has 
been increasing among MSM in Ireland in recent years and drug 
use among this population may be a contributory factor.
European MSM internet survey
The European Men-Who-Have-Sex-With-Men Internet 
Survey-2017 (EMIS-2017) was part of ESTICOM (European 
Surveys and Training to Improve MSM Community Health) and 
funded by the European Commission Health Programme 2014–
2020. The overall aim of EMIS-2017 was to generate data useful 
for the planning of HIV and sexually transmitted infection (STI) 
prevention and care programmes. EMIS-2017 was an online, 
behavioural surveillance survey designed to collect data from 
MSM living in 50 countries and included all 28 member states 
of the European Union. The EMIS-2017 study coordinators 
commissioned advertising on several dating platform apps 
that were used by MSM in each country. In Ireland, the EMIS-
2017 survey was advertised on: PlanetRomeo, Grindr, Hornet, 
RECON, Scruff, Gaydar, Manhunt/Jack’d and GROWLr. Overall, 
2,083 qualifying respondents were included in the Irish dataset 
and the results were recently published.3 The main findings 
regarding drug use among survey respondents are discussed 
below.
Results
Type of drug consumed
Participants were asked ‘When was the last time you consumed: 
cannabis (hashish, marijuana); synthetic cannabinoids; 
ecstasy; amphetamines; crystal meth; heroin or related drugs; 
mephedrone; synthetic stimulants other than mephedrone; 
ketamine; LSD; cocaine or crack cocaine?’ Overall, 41% of 
respondents used drugs in the last 12 months and 26% had 
used drugs in the last four weeks. The most commonly used 
drugs in the last 12 months were cannabis (34%), cocaine 
(20%), ecstasy pills (19%), and ecstasy powder (15%). In the last 
four weeks, cannabis and cocaine were used by 17% and 9% 
of respondents, respectively. Fewer than 1% of respondents 
indicated they had injected any drug to get high in the last 12 
months and just over 1% of respondents had injected anabolic 
steroids in the last 12 months.
Injecting drugs
Of men who indicated they injected drugs to get high in the last 
12 months (n=17), 59% had done so three times or less and three-
quarters of men had done it five times or less. Crystal meth was 
used by 83% of men who injected drugs, followed by ketamine 
(18%). Among men who had injected to get high in the last 12 
months (n=17), 29% had injected with a used needle or syringe.
Combining sex, drugs, and alcohol
Men who had sex with men in the last 12 months (n=1930) were 
asked ‘In the last 12 months, how much of the sex you’ve had 
with men has been under the influence of alcohol or any other 
drug?’ Over 45% indicated that they had some sex under the 
influence of alcohol or any other drug, while 12% said almost 
all or all sex was under the influence. Twenty per cent of all 
respondents had ever used stimulant drugs to make sex more 
intense or last longer and 14% had done so in the last 12 months. 
Stimulant drugs included in this definition were: ecstasy/
MDMA, cocaine, amphetamine, crystal meth, mephedrone, and 
ketamine. Overall, 75% of men who had used stimulant drugs 
during sex in the last 12 months had experience of doing so with 
more than one partner at once, with 61% doing so in the last 12 
months.
Conclusions
The authors noted that the prevalence of stimulant drug 
use among MSM during or before sex (ever) was higher in 
Ireland compared with the overall European prevalence (15%). 
Additionally, 72% of men who used stimulant drugs to make 
sex more intense or last longer had done so with more than 
one partner and this was also higher than the overall European 
proportion (66%). As chemsex has been associated with 
increased HIV and STI transmission, additional work is required 
to better understand chemsex and how best to mitigate the 
negative outcomes associated with it.
Seán Millar
1 McCarty-Caplan D, Jantz I and Swartz J (2014) MSM and drug use: 
a latent class analysis of drug use and related sexual risk behaviors. 
AIDS Behav, 18(7): 1339–1351.
2 Tomkins A, Ahmad S, Cannon L, Higgins S, Kliner M, Kolyva A, et al. 
(2018) Prevalence of recreational drug use reported by men who 
have sex with men attending sexual health clinics in Manchester, UK. 
Int J STD AIDS, 29(4): 350–356.
3 Casey C, O’Donnell K, Brady M and Igoe D (2019) EMIS-2017 Ireland: 
findings from the European Men Who Have Sex With Men Internet 
Survey (Ireland). Dublin: Health Protection Surveillance Centre. 
https://www.drugsandalcohol.ie/31180/
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National Sexual 
Assault Treatment 
Unit Services annual 
report, 2019
Sexual Assault Treatment Units (SATUs) provide clinical, forensic, 
and supportive care to victims of sexual violence in Ireland. 
There are six SATUs across Ireland, including Waterford, 
Mullingar, Dublin, Cork, Galway, and Letterkenny. SATUs 
offer three streams of care for survivors of sexual violence. 
These include forensic examination following the reporting 
of the crime to An Garda Síochána; health assessment and 
care without reporting the crime to An Garda Síochána; 
and healthcare and forensic examination with safe storage 
of evidence allowing for subsequent reporting to An Garda 
Síochána.
The national SATU services publishes an annual report on 
service provision. Identifying patterns and trends in service 
utilisation provides each SATU with the opportunity to adapt 
to service user needs. This article summarises the 2019 annual 
report.1
Key service user statistics
The SATU annual report collects key demographics on service 
users and service provision. Some 943 people attended these 
services in 2019. An additional two service users attended SATU 
in 2019 compared with 2018, representing a 1% increase of SATU 
attendance. This is the fifth consecutive year SATU attendance 
figures have increased. In 2019, some 93% of service users were 
female and the mean age of service users was 26 years.
Of the 943 reported incidents, 67% occurred indoors, with 21% 
in the assailant’s home and 21% in the victim’s home. Some 675 
(62%) of 1,084 perpetrators were described as ‘stranger’ or 
‘recent acquaintance’; 177 (17%) as ‘friend’ or ‘family member’; 
while 94 (9%) were described as an intimate (or ex-intimate) 
partner. Sixty-three per cent were referred to SATU by a 
member of An Garda Síochána and 16% were self-referrals.
Drug and alcohol use
The current report gathered statistics on service users’ drug 
and alcohol consumption. According to the findings, 422 (45%) 
had consumed more than six standard drinks, while 194 (21%) 
had consumed less than six standard drinks.2 Some 242 (26%) 
had consumed no alcohol in the 24 hours prior to the incident. 
In relation to drug consumption, 684 (73%) had not taken any 
drugs, 143 (15%) had taken recreational drugs, and 22 (2%) 
had taken both recreational and prescription drugs in the 24 
hours prior to the incident. Some 153 (16%) expressed concern 
that drugs (including alcohol) had been used to facilitate the 
sexual assault. According to data collected by the Rotunda 
Hospital SATU in Dublin, concern about drug-facilitated sexual 
assault has increased over the years, with 9% of service users 
expressing concern in 2017, 13% in 2018, and 20% in 2019.
Harm reduction and service improvement
To reduce the physical impact of sexual violence, all SATUs 
provide Chlamydia prophylaxis, hepatitis B vaccination, and risk 
assessment for HIV postexposure prophylaxis. In 2019, some 
64% of service users received Chlamydia prophylaxis, 61% 
commenced a hepatitis B immunisation programme, and 10% 
began postexposure prophylaxis for HIV. SATUs offer sexually 
transmitted infection screening at the initial appointment or 
at a follow-up appointment. This offer was availed of by 75% 
(n=709) service users in 2019. SATUs cater for the psychological 
wellbeing of service users through the provision of psychological 
support workers. A total of 920 service users engaged with a 
psychological support worker during their initial SATU visit.
The SATU dedication to service development and improvement 
is illustrated in the launch, publication, and implementation 
of the Department of Health’s SATU Policy Review3 to improve 
SATU services across the country. This includes upgrades to 
SATU environments. Continued education and upskilling of 
staff ensures the highest standard of service delivery. SATUs 
are striving to provide a more holistic service to attendees by 
encouraging attendance at follow-up, using a text reminder 
service and by providing referrals to other services. This 
interagency collaboration has also seen SATUs receive increased 
referrals from other services. Requests for education of schools 
and universities reflect a growing interest in reducing the impact 
of sexual violence in society. Representatives from SATUs deliver 
this education, which includes debunking rape myths and 
tackling issues of consent.
The Central Statistics Office (CSO) is currently undertaking a 
nationwide prevalence survey on sexual violence in Ireland.4 This 
survey intends to reflect changes in prevalence rates since the 
last survey was conducted on sexual violence in 20025 and to 
inform policy on sexual violence. 
Catherine Walshe
1 Eogan M (2020) National Sexual Assault Treatment Unit (SATU) 
annual report 2019. Dublin: National Sexual Assault Treatment Unit. 
https://www.drugsandalcohol.ie/32338/
2 One standard drink is a half-pint of beer, lager or stout (284 ml), a 
small glass of wine (100 ml) or a pub measure of spirits (35.5 ml).
3 Department of Health (2019) Department of Health policy review: 
Sexual Assault Treatment Units (SATUs). Dublin: Department of 
Health. Available online at:  
https://www.gov.ie/en/publication/e9ee89-department-of-health-
policy-review-of-the-national-sexual-assault-tr/ 
4 Central Statistics Office (CSO) (2019) Press release: CSO to oversee 
new national survey on the prevalence of sexual violence in Ireland. 
Cork: CSO. Available online at:  
https://www.cso.ie/en/csolatestnewspressreleases/2019 
pressreleases/csotooverseenewnationalsurveyontheprevalence 
ofsexualviolenceinireland/
5. McGee H, Garavan R, de Barra M, Byrne J and Conroy R (2002) 
The SAVI report: sexual abuse and violence in Ireland – a national 
study of Irish experiences, beliefs and attitudes concerning sexual 
violence. Dublin: Liffey Press.  
https://www.drugsandalcohol.ie/3793/ 
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20 Hepatitis C virus 
infection in Irish drug 
users and prisoners  
– a scoping review
Background and methods
The World Health Organization has set a goal to eliminate 
hepatitis C virus (HCV) as a global public health threat by 2030. 
Targets include reducing new HCV infections by 80%, the 
number of HCV deaths by 65%, and increasing HCV diagnoses 
from 20 to 90% and eligible people receiving HCV treatment 
from <5 to 80%.1 Unsafe injecting drug use is the main route 
of HCV transmission in developed countries.2 Consequently, 
people who inject drugs (PWID) in the general and prison 
population represent a priority population for HCV elimination, 
given the high prevalence and incidence in this group. However, 
the prevalence of HCV infection among PWID in Ireland remains 
poorly understood. A recent study aimed to map key previous 
findings and identify gaps in the literature (published and 
unpublished) on HCV infection in Irish PWID and prisoners.3
In this research, published in the BMC journal Infectious 
Diseases, a scoping review was carried out, guided by the 
methodological framework set out by Levac and colleagues 
(based on previous work by Arksey and O’Malley).4,5
Results
Two 2014 studies identified from the grey literature reported 
on HCV infection in PWID attending methadone maintenance 
therapy (MMT) in drug clinics outside of Dublin and reported 
an anti-HCV prevalence of 24% (Horan A (2014): Chart audit 
of HCV screening measuring the effect of chart labelling, 
unpublished).6 A published 2017 study reported an anti-HCV 
prevalence of 63.6% among PWID attending MMT at a north 
Dublin inner-city treatment centre.7
Two large HCV screening audits in 2016 reported an anti-HCV 
prevalence of almost 80% and a chronic HCV prevalence 
of 65% among PWID attending MMT at 23 drug treatment 
clinics in Dublin (Burke M (2016): Audit of HCV screening using 
retrospective patient records, unpublished). The most recent 
prevalence study in PWID attending opioid substitution therapy 
in general practice in Ireland reported an anti-HCV prevalence 
of 77.2%.8
With regard to the prison population, a 2014 study conducted 
in 13 of the 15 prisons in the Republic of Ireland reported an 
anti-HCV prevalence of 13% (95% CI: 10.9–15.2%) among the 
general prison population, increasing to 41.5% in prisoners with 
a history of injecting drug use and 54% in those with a history 
of injecting heroin.9 Another prison study from 2014 (single site) 
reported an HCV prevalence of 37% among prisoners on MMT.10
Conclusions
The authors noted that only two studies reported on HCV 
prevalence in PWID outside of Dublin and both were from 
secondary urban centres. In addition, the majority of the 
prevalence studies were over a decade old and only reported 
on anti-HCV prevalence and not on HCV RNA prevalence, 
which limits their usefulness at estimating the levels of chronic 
untreated infection and reinfection. Finally, the most recent 
epidemiological studies included in the review were mostly chart 
review audits, which limit their usefulness in informing policy and 
strategy.
Seán Millar
1 World Health Organization (WHO) (2017) Global hepatitis report 
2017. Geneva: WHO. https://www.drugsandalcohol.ie/27177/
2 Nelson P, Mathers B, Cowie B, Hagan H, Des Jarlais D, Horyniak 
D, et al. (2011) Global epidemiology of hepatitis B and hepatitis C 
in people who inject drugs: results of systematic reviews. Lancet, 
378(9791): 571–83. https://www.drugsandalcohol.ie/15845/
3 Crowley D, Murtagh R, Cullen W, Lambert JS, McHugh T and Van 
Hout MC (2019) Hepatitis C virus infection in Irish drug users and 
prisoners – a scoping review. BMC Infect Dis, 19(1): 702.  
https://www.drugsandalcohol.ie/31395/
4 Levac D, Colquhoun H and O’Brien KK (2010) Scoping studies: 
advancing the methodology. Implement Sci, 5: 69.
5 Arksey H and O’Malley L (2005) Scoping studies: towards a 
methodological framework. Int J Soc Res Methodol, 8: 19–32.
6 Ryan H and Ryan S (2014) Increasing incidence of hepatitis C among 
intravenous drug users in HSE Mid-West. NIHS Res Bull, 7(1): 32. 
https://www.drugsandalcohol.ie/22639/
7 Keegan D, Crowley D, Laird E and Van Hout MC (2017) Prevalence 
and risk factors for hepatitis C viral infection amongst a cohort 
of Irish drug users attending a drug treatment centre for agonist 
opioid treatment (AOT). Heroin Addict Relat Clin Probl, 19(1): 45–54. 
http://www.drugsandalcohol.ie/25815/
8 Murtagh R, Swan D, O’Connor E, McCombe G, Lambert JS, 
Avramovic G, et al. (2018) Hepatitis C prevalence and management 
among patients receiving opioid substitution treatment in general 
practice in Ireland: baseline data from a feasibility study. Interact J 
Med Res, 7(2): e10313. https://www.drugsandalcohol.ie/30874/
9 Drummond A, Codd M, Donnelly N, McCausland D, Mehegan J, 
Daly L, et al. (2014) Study on the prevalence of drug use, including 
intravenous drug use, and blood-borne viruses among the Irish 
prisoner population. Dublin: National Advisory Committee on Drugs 
and Alcohol. https://www.drugsandalcohol.ie/21750/
10 Galander T, Rosalim J, Betts-Symonds G and Scully M (2014) A 
survey of patients on methadone programmes in Wheatfield Prison, 
Dublin, Ireland. Heroin Addict Relat Clin Probl, 16(2): 17–22.  
https://www.drugsandalcohol.ie/23736/
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Estimating the 
seroprevalence of 
untreated chronic 
HCV infection in 
Mountjoy Prison
Background and methods
Unsafe injecting drug use is the main route of hepatitis C 
virus (HCV) transmission in developed countries,1 and it is 
generally acknowledged that people who inject drugs (PWID) 
and HCV infection are typically over-represented in prison 
populations across Europe.2 A 2016 meta-analysis reported a 
prison HCV prevalence in Western Europe of 15.5%, with this 
prevalence increasing to over 40% among those prisoners with 
a history of injecting drug use (IDU).3 However, the prevalence 
of HCV infection among prisoners in Ireland remains poorly 
understood. In addition, most epidemiological studies among 
PWID and prisoners report on HCV antibody prevalence 
(exposure) and not the presence of HCV RNA. Thus, they do not 
differentiate between treated chronic infection with sustained 
viral response (SVR) and the 20–30% of HCV-infected people 
who spontaneously clear HCV without treatment. A recent 
study aimed to estimate the seroprevalence of untreated 
chronic HCV infection and to identify associated risk factors in 
an Irish male prison population.4
In this research, published in the journal Eurosurveillance, the 
authors conducted a cross-sectional study in Mountjoy Prison, 
Dublin involving a researcher-administered questionnaire, 
review of medical records, and HCV serology. All prisoners were 
offered screening for blood-borne viruses, including reflex RNA 
testing and genotyping.
Results
Of the 422 prisoners (78% of the study population) who 
participated in the study, 298 (70.6%) completed the 
questionnaire and 403 (95.5%) were tested for HCV antibodies. 
Of those tested, 92 (22.8%) were HCV antibody-positive. Of 
those antibody-positive, 53 (57.6%) were HCV RNA-positive; 23 
(25%) had spontaneous clearance; 16 (17.4%) had a SVR; 10 (11%) 
were co-infected with HIV and 6 (6%) with hepatitis B virus. The 
untreated chronic HCV seroprevalence estimate was 13.1% and 
the seroprevalence of HCV among prisoners with a history of 
IDU was 79.7%.
Risk factors significantly associated with past HCV infection were 
IDU (p<0.0001); having received a prison tattoo (p<0.0001) or a 
non-sterile community tattoo (p<0.0001); and sharing needles 
and other drug-taking paraphernalia (p<0.0001). On multivariable 
analysis, history of receiving a non-sterile community tattoo was 
the only significant risk factor associated with HCV acquisition 
(after IDU was removed from the model) (p=0.005).
Conclusions
The authors concluded that the level of untreated chronic 
HCV infection in Irish prisons is high, with IDU being the main 
associated risk. The reporting of HCV infection in prisoners in 
this way is unique in both the Irish and international literature 
and allows for the estimation of the true levels of active 
HCV infection, the monitoring of treatment outcomes, and 
rates of reinfection. Identifying risk factors for HCV infection 
may allow for targeted prevention, screening, and treatment 
strategies. Combined, these may help to inform planning and 
implementation of national and international HCV strategies.
Seán Millar
1 Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak 
D, et al. (2011) Global epidemiology of hepatitis B and hepatitis C 
in people who inject drugs: results of systematic reviews. Lancet, 
378(9791): 571–583. https://www.drugsandalcohol.ie/15845/
2 Larney S, Kopinski H, Beckwith CG, Zaller ND, Jarlais DD, Hagan H, 
et al. (2013) Incidence and prevalence of hepatitis C in prisons and 
other closed settings: results of a systematic review and meta-
analysis. Hepatology, 58(4): 1215–1224.
3 Dolan K, Wirtz AL, Moazen B, Ndeffo-Mbah M, Galvani A, Kinner SA, 
et al. (2016) Global burden of HIV, viral hepatitis, and tuberculosis in 
prisoners and detainees. Lancet, 388(10049): 1089–1102.  
https://www.drugsandalcohol.ie/25800/
4 Crowley D, Lambert JS, Betts-Symonds G, et al. (2019) The 
seroprevalence of untreated chronic hepatitis C virus (HCV) 
infection and associated risk factors in male Irish prisoners: a cross-
sectional study, 2017. Euro Surveill, 24(14): 1800369.  
https://www.drugsandalcohol.ie/31182/
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20 Senior management 
perspectives on 
needle exchange 
provision in Irish 
prisons
Background and methods
Unsafe injecting drug use is the main route of hepatitis C virus 
(HCV) transmission in developed countries.1 Consequently, 
people who inject drugs (PWID) in the general and prison 
population represent a priority population for HCV elimination, 
given the high prevalence and incidence in this group. The 
current national drugs strategy2 aims to reduce harms arising 
from substance misuse and to reduce the prevalence of 
blood-borne viruses among PWID through the expansion 
of needle exchange. In Ireland, this service is delivered in a 
number of ways, including fixed-site locations such as clinics 
or community pharmacies and novel interventions such as 
Backpacking Outreach programmes. However, in 2020, there 
is no needle exchange provision in Irish prisons. A recent study 
examined the views of six senior managers, employed as prison 
health staff and security management, in order to discover 
attitudes towards needle exchange provision within Irish 
prisons, as an element of prisoner health service provision in 
the context of wider service provision for drug users within the 
prison system.3
In this research, published in the Journal of Correctional 
Health Care, data were collected in Dublin, using face-to-face, 
non-standardised, semi-structured interviews in May 2014. 
They were thematically analysed using subjective narratives that 
were recorded and transcribed.
Results
Impact of changing dynamics of prison drug use
A majority of the participants agreed that in Ireland, as in other 
jurisdictions, drug use occurs in prisons. However, research 
participants claimed that at present there was minimal injecting 
drug use and needle sharing in Irish prisons and that needles 
were generally not found in searches. They also reported that 
there were no verbal reports or physical evidence of injecting 
drug use and that no significant incidents of needle sharing are 
emerging or recorded in the prison medical record system. It 
was asserted that drug culture in prison had shifted compared 
with 15 years ago. Research participants argued that the 
catalyst for this change away from an injecting drug use culture 
in Irish prisons was the availability and remarkable success of 
methadone maintenance as a treatment option for opiate-
dependent prisoners.
Operational and logistic issues and challenges
The expressed opposition to the introduction of needle 
exchange to the Irish prison system was not, however, 
solely attributable to new evidence that injecting drug use 
has declined significantly among the prison population. It 
was also linked to strong ideological conflict expressed by 
the participants. In particular, it was suggested that the 
introduction of needle exchange generally implies condoning 
prison drug use. Also, participants expressed the view that there 
was a high level of concern from prison staff members in relation 
to ‘perceived threat to own safety’ should needle exchange 
provision be introduced. The risks in question refer to assaults 
by prisoners on staff involving needles, similar conflict between 
prisoners, and accidental sharps injury from unsafe disposal of 
drug paraphernalia. All participants felt that the introduction 
of needle exchange provision would pose serious logistical and 
operational challenges. Furthermore, it was contended that 
prisoners who were likely to avail of needle exchange were those 
who were generally more ‘chaotic in their lives’. The majority of 
participants conceded that prisoners, like other citizens, have 
individual civil rights. However, it was argued that these rights 
were of necessity curtailed in the prison environment. Thus, it 
was assumed that if a prisoner was convicted, they were entitled 
to minimal consideration.
Needle exchange as a policy development
Although participants felt that the evidence supporting needle 
exchange provision has been quite convincing in prisons in other 
jurisdictions, it was suggested that injecting drug culture was 
more prevalent in the prison systems of these other countries 
and that such a harm reduction scheme was unnecessary in 
Ireland. In addition, it would be difficult to introduce needle 
exchange due to role conflict between the professional duties to 
the care of prisoners while in custody and implied obligations to 
prison administration. Furthermore, the introduction of needle 
exchange provision in Irish prisons would entail changes in 
legislation and institutional prison policy regulations. Participants 
also expressed doubt that the general public would accept the 
concept of needle exchange in Irish prisons, as drugs are not 
meant to be used there in the first place.
Conclusions
The authors noted that research participants were generally 
opposed to the introduction of prison needle exchange in 
Ireland, suggesting that injecting drug use within Irish prisons has 
declined and that making needles freely available to prisoners 
would make prisons riskier since these needles might be used 
as weapons against prison staff or other prisoners. However, the 
study authors also observed that opposition to prison needle 
exchange provision had a strong symbolic component. This was 
in the sense that to introduce this form of harm reduction to 
Irish prisons might be seen as condoning illicit drug use and 
sending out the ‘wrong message’ in relation to the criminal 
justice system’s approach to this matter
Seán Millar
1 Nelson PK, Mathers BM, Cowie B, Hagan H, Jarlais DD, Horyniak 
D, et al. (2011) Global epidemiology of hepatitis B and hepatitis C 
in people who inject drugs: results of systematic reviews. Lancet, 
378(9791): 571–583. https://www.drugsandalcohol.ie/15845/
2 Department of Health (2017) Reducing harm, supporting recovery: a 
health-led response to drug and alcohol use in Ireland 2017–2025. 
Department of Health, Dublin.  
https://www.drugsandalcohol.ie/27603/
3 Rosalim JP (2020) A senior management perspective on the policy 
debate of needle and syringe exchange program provision in Irish 
prisons. J Correct Health Care, 26(1): 27–35.  
https://www.drugsandalcohol.ie/31593/
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Prison visiting 
committee annual 
reports, 2018
A visiting committee is appointed to each Irish prison under 
the Prisons (Visiting Committees) Act 1925 and the Prisons 
(Visiting Committees) Order 1925. Members of the 12 visiting 
committees are appointed by the Minister for Justice and 
Equality for a term not exceeding three years. The function of 
prison visiting committees is to visit, at frequent intervals, the 
prison to which they are appointed and hear any complaints 
that may be made to them by any prisoner. They report to the 
Minister for Justice and Equality regarding any abuses observed 
or found, and any repairs which they think are urgently needed. 
Prison visiting committee members have free access, either 
collectively or individually, to every part of the prison to which 
their committee is appointed. Information from prison visiting 
committee reports relating to drug use in prisons for 2018 is 
summarised below.1
Mountjoy Prison, Dublin
In its report, the Mountjoy Visiting Committee2 noted that 
substance abuse and related activity is contributing to risk 
to both prisoners and staff, with a reported increase in 
intimidation, violence, and injury to physical and mental health. 
Practices and endeavours to disrupt the inflow of drugs need 
continued attention in the interests of both prisoners and staff. 
The committee also observed that a number of male prisoners 
enter the prison from conditions where physical, mental, and 
dental health may have been chronically neglected due to 
substance abuse and other circumstances. Consequently, it is 
likely that the most vulnerable individuals are falling through 
the gaps in community-based mental health services and are 
sentenced to imprisonment where mental health problems and 
the risk of self-harm may be intensified.
The lack of permanent posts in the treatment teams and the 
significant shortage of beds in a secure mental-health inpatient 
treatment unit were also noted as a cause of serious concern. 
The committee heard that prisoners regularly highlight their 
wish for drug addiction counselling and furthermore for a drug-
free section in the prison following effective treatment. The 
committee stated that it is regrettable that some prisoners who 
successfully complete drug treatment regress while awaiting 
supportive accommodation in transition, or when they return 
to inadequate services in the community.
Dóchas Centre, Dublin
The Dóchas Visiting Committee noted in its report3 that they 
had received complaints about the presence of illicit drugs 
within Dóchas. Many women had told the committee that they 
are afraid to leave their rooms for fear of aggressive behaviour 
from prisoners under the influence of illicit drugs. The 
committee observed that this problem appeared to be growing 
and urged that all the necessary resources be used to tackle 
this serious development.
Wheatfield Prison, Dublin
The Wheatfield Place of Detention Visiting Committee’s report4 
observed that the Wheatfield yards are large spaces. Although 
the yards are covered with netting in order to prevent drugs and 
objects being thrown over the perimeter wall, this continues 
to be a considerable difficulty for the authorities in Wheatfield 
Prison. The committee recommended that more netting and 
a solution to the security of the perimeter wall are essential to 
prevent illicit contraband entering the prison. The committee 
also noted that illicit drugs continue to be a serious and ongoing 
difficulty both for the prison authorities and also for prisoners 
and their families. Despite the best efforts of the authorities 
in Wheatfield Prison, scanners, sniffer dogs, X-ray and bags 
searches, and the perimeter wall being monitored daily, drugs 
continue to enter the prison.
Cloverhill Prison, Dublin
In its report, the Cloverhill Visiting Committee5 noted that the 
issue of drugs and security measures at Cloverhill remain a 
deep concern. In particular, drugs coming over the wall from 
boundaries outside the prison confines and over the netting 
continue to be a huge problem, given the increase in drugs from 
this source. The committee was informed that when prisoners 
retrieve some of these drugs, by climbing walls, it can lead to 
serious injury, with one hospitalisation in 2018. The committee 
was told that the problem is being addressed by prison 
authorities, with extensive building work being carried out to 
secure netting and any areas of the perimeter that allow access 
to prisoners.
Arbour Hill Prison, Dublin
The Arbour Hill Visiting Committee’s report6 noted that incidents 
relating to drugs within the prison remained exceptionally low 
in 2018, and complimented the prison management and staff 
on this matter. Arbour Hill remains fully committed to ensuring 
that the prison remains drug-free. All prisoners are fully aware 
that they are expected to be 100% drug-free and access to the 
prison’s facilities and services depend on this. Random drug 
testing is part of the day-to-day routine at the prison.
Shelton Abbey Prison, Co. Wicklow
The Shelton Abbey Visiting Committee’s report7 noted that 
a full-time addiction counsellor was appointed in 2017, who 
is respected by offenders and noted as a trusted listener. A 
number of addiction-related programmes took place at Shelton 
Abbey during 2018.
Seán Millar
1 Department of Justice and Equality (2020) Prison visiting committee 
annual reports 2018. Dublin: Department of Justice and Equality. 
Available online at:  
http://www.justice.ie/en/JELR/Pages/Prison_Visiting_Committee_
Annual_Reports_2018
2 Mountjoy Visiting Committee (2020) Annual report for 2018 to 
Minister for Justice and Equality Charles Flanagan TD from 
Mountjoy Visiting Committee. Dublin: Department of Justice and 
Equality. https://www.drugsandalcohol.ie/32084/
3 Dóchas Visiting Committee (2020) 2018 Annual report Dóchas 
Visiting Committee. Dublin: Department of Justice and Equality. 
https://www.drugsandalcohol.ie/32084/
4 Wheatfield Place of Detention Visiting Committee (2020) Visiting 
Committee 2018 annual report for Wheatfield Prison. Dublin: 
Department of Justice and Equality.  
https://www.drugsandalcohol.ie/32084/
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5 Cloverhill Visiting Committee (2020) Annual report 2018 from 
Cloverhill Visiting Committee to the Minister for Justice and 
Equality Charles Flanagan TD. Dublin: Department of Justice and 
Equality. https://www.drugsandalcohol.ie/32084/
6 Arbour Hill Visiting Committee (2020) Arbour Hill Prison Visiting 
Committee annual report 2018. Dublin: Department of Justice 
and Equality. https://www.drugsandalcohol.ie/32084/
7 Shelton Abbey Visiting Committee (2020) Visiting Committee 
annual report 2018: Shelton Abbey. Dublin: Department of Justice 
and Equality. https://www.drugsandalcohol.ie/32084/
Prison visiting committees   continued
RESPONSES
Ana Liffey Drug 
Project annual 
report, 2018
The Ana Liffey Drug Project (ALDP) is a ‘low-threshold, harm 
reduction’ project working with people who are actively 
using drugs and experiencing associated problems. ALDP has 
been offering harm reduction services to people in the north 
inner-city area of Dublin since 1982, from premises at Middle 
Abbey Street. ALDP offers a wide variety of low-threshold, 
harm reduction services that offer pathways for drug users 
out of their current circumstance, including addiction and 
homelessness.
The services offered in Dublin are:
• Open access
• Assertive outreach
• Needle and syringe programme
• Medical services
• Stabilisation group
• Detox group
• Harm reduction group
• Treatment options group
• Assessment for residential treatment
• Key working and case management
• Prison in-reach.
Nursing services
In Dublin, nursing services are provided on a drop-in basis. 
Services offered include blood-borne virus testing, wound 
care, and compression bandaging. ALDP also provides an 
in-reach nursing service to the residents of Crosscare Cedar 
House every Tuesday from 3.00 pm to 4.30 pm. In addition 
to providing nursing services on a daily basis, ALDP works in 
partnership with Safetynet Primary Care to provide a GP clinic 
every Friday between 11.30 am and 1.30 pm.
Mid-West region
The ALDP Mid-West region provides harm reduction services in 
Limerick city and three counties to people affected by problem 
substance use, their families, and the wider community. The 
counties served are Limerick, Clare, and North Tipperary. The 
ALDP Online and Digital Services team also offers support and 
information to the general public and to drug users, as well as 
to other agencies that work with problem drug users.
Annual report
The ALDP annual report was published in 2019.1 It noted that 
Dublin open access services provided help to 982 individuals 
in 2018, the majority of whom were homeless and many were 
polydrug users with mental and physical health problems; 
151 individuals received key working and case management; 
437 people attended treatment groups; and 538 individuals 
used the needle and syringe programme. ALDP also provided 
in-reach services to Mountjoy Prison, where 54 individuals 
attended groups run in this setting.
In the Mid-West, ALDP served a similar cohort of people: 281 
people were registered with the service in 2018. Of these, 75 
individuals accessed case management services and 129 people 
accessed the ALDP needle and syringe programme.
September 2018 saw the winding down of the Online and 
Digital Services team at ALDP. The team managed the Drugs.
ie website, which had 1,754,779 visits from its inception to 
September 2018. During this period, the team also received 809 
calls through the Live Helper chat service.
Seán Millar
1 Ana Liffey Drug Project (2019) Ana Liffey Drug Project annual 
report 2018. Dublin: Ana Liffey Drug Project.  
https://www.drugsandalcohol.ie/31432/
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Adolescent Addiction 
Service report, 2020
The Adolescent Addiction Service (AAS) of the Health Service 
Executive (HSE) provides support and treatment in relation to 
alcohol and drug use for young people and families from the 
Dublin suburbs of Ballyfermot, Clondalkin, Palmerstown, Lucan, 
and Inchicore. Services provided include advice, assessment, 
counselling, family therapy, professional consultations, and 
medications if required. In 2020, AAS published a report 
detailing referrals for 2019.1
Referrals
In 2019, AAS worked with 49 young people and their families, 
with a mean age of 15.3 years (range: 13–18 years). This figure 
includes new referrals, re-referrals, and continuances. The 
majority (90%) were male and 12% were non-Irish nationals. In 
terms of referral areas, the greatest numbers of referrals were 
from Clondalkin followed by Lucan, Ballyfermot, Palmerstown, 
and Inchicore.
Drug and alcohol use
Cannabis (weed) continued to be the main substance 
used by clients at 96%, while alcohol use was at 67% (see 
Figure 1). Other substances of use included cocaine (29%), 
benzodiazepines (28%), amphetamines (22%), and opiates (2%). 
Solvents and head-shop-type products did not feature among 
young people’s substance use in 2019. The report noted that 
the biggest change concerning secondary drug use related 
to increases in benzodiazepine use by 16% as well as the 
introduction of ‘eatables’, i.e. edibles. There were decreases 
in amphetamine use by 8% and cocaine by 7% compared with 
2018.
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Figure 1: Main substances used by AAS clients, 2019
Source: HSE AAS (2020)
Other issues
Other issues that presented related to absconding, 
indebtedness, and holding, distributing or dealing drugs. The 
service submitted child protection notifications and also 
held interagency meetings in relation to 10 young people. Of 
those who exited treatment, 62% had a planned discharge, 
33% declined further treatment, and 5% moved out of 
the community or returned to the community of origin. 
The majority of young people (94%) were seen by a family 
therapist only, with 6% having a psychiatric assessment and 4% 
prescribed medication.
Conclusions
The report authors noted that, as in previous years, most 
young people had established patterns of substance use prior 
to referral and, as a consequence, some struggle to maintain 
a drug-free status. Nevertheless, most achieve stability and 
several remain abstinent. They concluded that there is a need 
for parents and non-parental adults to identify young people 
within risk groups at an early stage and to elevate concern for 
them.
Seán Millar
1 Adolescent Addiction Service (2020) Adolescent Addiction Service 
report 2020. Dublin: Health Service Executive.  
https://www.drugsandalcohol.ie/31890/
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Category 2018 Total since March 2015
Illicit drugs €28,158,570 €146,958,010
Firearms 23 91
Rounds of ammunition 122 3016
Cash €2,796,073 €8,317,583
Arrests for drug trafficking, money laundering, possession of 
firearms and kindred offences 191 518
Threat-to-life operations 13 59*
Table 1: Summary of seizures by GNDOCB
Source: AGS annual report, 2018, p. 7
* 59 relates to threat-to-life operations carried out since the murder of David Byrne at the Regency Hotel, Dublin on 5 February 2016. Included in the threat-to-life 
operations figure are Special Crime Task Force arrests as well as drug seizures and arrests from controlled delivery operations carried out in conjunction with Customs and 
Revenue Service.
An Garda Síochána 
annual report, 2018
In December 2019, An Garda Síochána (AGS) published 
their annual report for 2018.1 While 2018 was considered a 
challenging year for AGS, it was also viewed positively. The 
report identifies where targets from the 2018 Policing Plan2,3 
were fully and partially met and where they were not. This 
article will first report on activities related to national policing; 
followed by national security and intelligence; community 
safety; statistics for detections of incidents related to the sale 
and supply of drugs; and Garda drug seizures for 2018.
National policing
Gardaí work in various units to fight crime across Ireland. What 
follows is a brief outline of a selection of the work undertaken 
by some of these units.
National Criminal Intelligence Unit
The National Criminal Intelligence Unit (NCIU) works with 
national and local investigation units with the aim of finding, 
stopping, and dismantling organised crime groups. The 
main point of contact within NCIU is the National Criminal 
Intelligence Officer (NCIO). Its role is to provide other CIOs 
within AGS with information and intelligence on incidents as 
they arise.
Garda National Drugs and Organised Crime Bureau
Table 1 provides a breakdown of seizures relating to operations 
carried out by the Garda National Drugs and Organised Crime 
Bureau (GNDOCB) in 2018.
Operation Thor
Operation Thor, AGS’s national anti-burglary operation, 
commenced in November 2015. Between November 2015 
and 31 December 2018, there were 9,200 arrests and 177,460 
checkpoints. The incidence of burglary in residential (n=41,588) 
and non-residential (n=15,481) settings decreased by 35% and 
23%, respectively.
Garda National Protective Services Bureau
The Garda National Protective Services Bureau (GNPSB) targets 
suspects involved in online child exploitation, child sexual 
abuse, and human trafficking. Operation Ketch, managed by the 
Online Child Exploitation Unit (OnCE), targeted suspects who 
possess, import, and supply child abuse material online. Overall, 
OnCE identified 137 targets in 137 searches under warrant. In 
2018, some 56 children that were being exploited online were 
identified by the Victims Identification Unit. Human trafficking 
increased by 25% between 2017 (n=51) and 2018 (n=64).
GNPSB also works with agencies in the United Kingdom (UK) 
(e.g. National Crime Agency and North Wales Police) to identify 
bodies of individuals found on the west coast of the UK who 
may have been reported missing in Ireland. From its inception 
in January 2017 to 2018, comparative analysis utilising familial 
DNA resulted in 10 individuals being identified.
Garda National Cyber Crime Bureau
The Garda National Cyber Crime Bureau (GNCCB) assisted 
in several enquiries: child pornography (248 cases); theft 
and fraud (83 cases); child exploitation/grooming (31 cases); 
data retrieval (30 cases); and sexual assault/rape (19 cases). 
It provided technical support on several operations. For 
example, in Operation Myriad, which targeted organised crime 
groups involved in fraud, money laundering, and forgery, 50 
exhibits were examined. Similarly, serious crime investigations 
were supported in forensic examination of exhibits related 
to murder, organised criminal gangs, missing persons, and 
terrorism.
Criminal Assets Bureau
In 2018, the Criminal Assets Bureau (CAB) targeted ‘lower level’ 
associates of major organised crime gangs with the aim of 
‘disrupting’ their advancement within these organisations. The 
main crime categories focused on included:
• Robberies
• Stolen vehicles
• Sale and supply of controlled drugs
• Sale of encrypted devices
• International mail fraud scams
• Fuel and tobacco smuggling.
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Operational support services
AGS has several operational support units to support its work: 
the Garda Air Support Unit (GASU), Garda Dog Unit, Garda 
Mounted Unit, and Garda Water Unit.
• GASU: In March 2018, GASU provided support to local fire 
services at a hotel fire in Ballymun, Dublin by providing live 
aerial pictures to personnel, enabling the identification of 
hotspots, secondary fires, and people who may be trapped.
• Garda Dog Unit: The unit carried out 1,648 searches in 
2018 to find missing persons, drugs, firearms, explosive 
substances, and stolen property.
• Garda Mounted Unit: The aim of this unit is mainly crime 
prevention. It has provided high-visibility patrols as part of 
Operation Thor and covers public events, crowd control, 
and VIP protection.
• Garda Water Unit: In 2018, this unit recovered 10 bodies as 
part of humanitarian missing person searches.
National security and intelligence
Security and intelligence
The national security and intelligence section provides 
intelligence to units working to detect and examine threats 
to Ireland from terrorists and organised crime gangs. The 
threat level in 2018 was ‘moderate’, indicating that ‘an attack 
is possible but unlikely’ (p. 14). Table 2 provides an overview of 
some of the work carried out by this section.
Unit Activities during 2018
Special Detective Unit (SDU)
• Security screening of 300 refugees under the 
Government’s Irish Refugees Resettlement Programme
• Antiterrorist operations (national and international)
• 12 persons convicted before the Special Criminal Court 
for terrorist-related activities
Special Tactics and Operations Command (STOC):
National Negotiation Unit • 98 hostage/barricade/suicide type incidents; 60%  related to mental health
Emergency Response Unit 
• Close protection for four royal visits and a papal visit
• Deployed nationally on high profile operations
• Assisted colleagues in CAB, National Surveillance Unit, 
SDU, and GNDOCB
Armed Support Unit 
• Operated from 11 centres in 2018
• High-visibility presence for papal visit, St Patrick’s Day 
parades, and Dublin City Marathon
An Garda Síochána annual  
report, 2018   continued
Table 2: Actions taken by the security and intelligence section to keep Ireland safe
Source: AGS annual report, 2018, pp. 15–17
Liaison and protection
Within AGS, the Garda Síochána Analysis Service evaluated 
national initiatives, such as Sex Offender Risk Assessment and 
Management (SORAM), and contributed to national strategies. In 
addition, AGS continued to work closely with agencies outside 
Ireland. Its activities included:
• Multiagency terrorism exercise: AGS tested response 
capabilities in the event of terrorist attacks in Operation 
Barracuda.
• Fixed Interpol Network Database (FIND): AGS can query 
information on stolen/lost travel paperwork 24/7. Between 
November 2016 and February 2019, some 23,976,128 checks 
were carried out on passengers arriving in Ireland by air and 
sea.
• Interpol European Regional Conference: This conference 
was hosted by AGS in Dublin; 229 delegates and observers 
attended.
• Europol: AGS supported several European Joint Action 
Days, such as cyberattacks, human trafficking, and cocaine 
trafficking. In addition, they contributed to Europol’s 
Organised Crime Threat Assessment, the Internet Organised 
Crime Threat Assessment, and reports on terrorism in the 
European Union.
• International Coordination Unit (ICU): AGS continued 
to manage the National Internal Security Fund Project, 
focusing on projects that prioritised policing and security.
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report, 2018   continued
Community safety
Community engagement is at the heart of the work of AGS. 
Several activities were carried out in 2018, such as crime 
prevention campaigns (e.g. burglary prevention, public assaults, 
online safety), Crimecall, Campus Watch, and the Joint Agency 
Response to Crime Conference.
Statistics
Incidents of sale and supply of drugs marked  
as detected
Figure 1 shows the number of sale and supply incidents 
detected between 2013 and 2018. Between 2013 and 2015, 
there was on average 311 incidents per month. Between 2016 
and 2018, there was on average 285 incidents per month. The 
report states that the detection figures should be interpreted 
with caution as the PULSE system used to record detections 
was upgraded in February 2018. Hence, detections before and 
after the upgrade cannot be compared.
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Figure 1: Detected incidents of sale and supply of drugs
Source: Operational PULSE data ICCS types: 1011, 1012, 1021, AGS annual report, 2018, p. 45
Garda-only drug seizures, 2018
Drug seizures are submitted to Forensic Science Ireland (FSI) for 
analysis. Overall, it was estimated that the value of drugs seized 
by Gardaí in 2018 was €30,696,694. As illustrated in Table 3, 
the most prominent drugs seized in Ireland with values greater 
than €1 million were cannabis herb, cocaine, cannabis plants, 
diamorphine, phenethylamines, benzodiazepines, and cannabis 
resin. While cannabis plants are ranked third, it is likely that this 
figure is higher, as not all plants are sent to FSI for analysis.
Conclusion
Garda Commissioner Drew Harris acknowledged the ‘dedication 
and determination of Garda members, staff and reserves 
to keeping people safe’ (p. 2). Evidence of this work is seen 
throughout the report, from significant drug seizures, reductions 
in burglaries, education initiatives on shielding themselves from 
crime to positive engagements with communities across Ireland 
(p. 3).
Commissioner Harris stated that the main goal of AGS is the keep 
people safe. This can be achieved by delivering an ‘efficient, 
effective and ethical police and security service’ (p. 3). He 
acknowledged that significant advances were made to achieve 
this goal in 2018 and is confident that the provision of services to 
the public and the State by AGS will progress further in 2019 (p. 3).
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report, 2018   continued
Category Grams/mls/plant Tbls/sqr/caps Value
Cannabis herb 380,147 440 €7,602,950
Cocaine 91,047 2 €6,373,261
Cannabis plants* 7,186 - €5,748,481
Diamorphine 38,714 2 €5,419,892
Phenethylamine** 30,486 102,350 €2,241,542
Benzodiazepine 26,711 912,327 €1,622,036
Cannabis resin 179,127 - €1,074,762
Cathinones 5,843 11,710 €292,165
Hallucinogen 11,208 470 €180,411
Sleeping tablets 10,095 45,347 €90,694
Mixing agents 39,772 291 €19,886
New psychoactive substances 300 - €14,995
Synthetic cannabinoid 616 - €12,312
Solvent 2,370 12 €2,370
Anabolic steroids 32 956 €574
Opioids other 1,814 3 €363
Piperazine - - -
Total €30,696,694
Table 3: Garda drug seizures, 2018
Source: AGS annual report, 2018, p. 49
* Cannabis plants are calculated based on figures recorded on PULSE as not all plants seized are routinely sent to FSI.
** Phenethylamines include ecstasy (MDMA) and other similar related drugs.
Ciara H Guiney
1 An Garda Síochána (2019) An Garda Síochána: annual  
report 2018. Dublin: An Garda Síochána.  
https://www.drugsandalcohol.ie/32192/
2 An Garda Síochána Strategic Planning Unit (2018) An Garda 
Síochána annual policing plan, 2018. Dublin: An Garda Síochána. 
https://www.drugsandalcohol.ie/29169/
3 Guiney CH (2018) An Garda Síochána policing plan 2018.  
Drugnet Ireland, 67 (Autumn): 20–21.  
https://www.drugsandalcohol.ie/29934/
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Recent publications
PREVALENCE AND CURRENT SITUATION
Drinking in denial: a cross-sectional analysis of national  
survey data in Ireland to measure drinkers’ awareness of  
their alcohol use
Mongan D, Millar SR, O’Dwyer C, Long J and Galvin B (2020)  
BMJ Open, 10(7): e034520. 
https://www.drugsandalcohol.ie/32429/
The aim of this study was to determine awareness of drinking 
pattern in an Irish population using a representative random 
sample and to identify characteristics associated with self-
awareness of hazardous or harmful drinking.
The results of this study suggest that patterns of alcohol use 
in Ireland are problematic. Older respondents and those with 
lower educational attainment are less likely to be aware of their 
hazardous or harmful drinking pattern. There is also a population 
of younger, more-educated drinkers who engage in potentially 
risk-taking behaviours and these subjects are aware of their 
harmful drinking pattern. Initiatives to reduce overall alcohol 
consumption and raise awareness around drinking patterns are 
required.
A national model of remote care for assessing and  
providing opioid agonist treatment during the Covid-19 
pandemic: a report
Crowley D and Delargy I (2020) Harm Reduction Journal, 17: 49. 
https://www.drugsandalcohol.ie/32420/ 
In response to Covid-19, healthcare is increasingly being delivered 
by telephone and video consultation, and this report describes 
the development of a national model of remote care to eliminate 
waiting lists and increase access to OAT [opioid agonist treatment] 
in Ireland.
The development of a remote model of healthcare delivery allows 
for the reduction in transmission risks associated with Covid-19, 
increases access to OAT, reduces waiting times and minimises 
barriers to services. An evaluation of this model is ongoing 
and will be reported once completed. Fast adaptation of OAT 
delivery is critical to ensure access to and continuity of service 
delivery and minimise risk to our staff, patients and community. 
Innovative models of remote healthcare delivery adapted during 
the Covid-19 crisis may inform and have important benefits to our 
health system into the future.
National Drugs Library
Retention of patients in opioid substitution treatment:  
a systematic review
O’Connor AM, Cousins G, Durand L, Barry J and Boland F (2020) 
PLoS ONE, 15(5): e0232086.  
https://www.drugsandalcohol.ie/32009/
This systematic review aims to identify both protective factors 
supporting retention in OST [opioid substitution treatment], and 
risk factors for treatment dropout.
Younger age, substance use, particularly cocaine and heroin 
use, lower doses of methadone, criminal activity/incarceration, 
and negative attitudes to MMT [methadone maintenance 
treatment] appear to be associated with reduced retention in 
OST. A consensus definition of retention is required to allow for 
comparability across future studies.
Patients' experiences of engagement with healthcare services 
following a high-risk self-harm presentation to a hospital 
emergency department: a mixed methods study
Cully G, Leahy D, Shiely F and Arensman E (2020) Archives of 
Suicide Research, Early online.  
https://www.drugsandalcohol.ie/32267/
This study addressed the experiences of engaging with healthcare 
services following a self-harm presentation to hospital of 
high lethality or high suicidal intent by documenting patients' 
experiences.
Our findings show that satisfaction with services, help-seeking and 
treatment adherence may be improved by ensuring the consistent 
provision of timely, comprehensive and supportive aftercare 
following a HRSH [high-risk self-harm] presentation. Absence 
of these aspects of care may contribute to ongoing distress and 
further suicidal behavior.
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The challenges of COVID-19 for community pharmacists and 
opportunities for the future
Hayden JC and Parkin R (2020) Irish Journal of Psychological 
Medicine, 37(3): 198–203. 
https://www.drugsandalcohol.ie/32165/
This article reviews the pandemic-related challenges and 
responses by pharmacists, as well as forming recommendation for 
areas of professional support and role expansion, particularly in 
the case of mental health.
The psychological impact of childhood homelessness – a 
literature review
D’Sa S, Foley D, Hannon J, Strashun S, Murphy A-M and O’Gorman 
C (2020) Irish Journal of Medical Science, Early online. 
https://www.drugsandalcohol.ie/32150/
Our aim was to evaluate current knowledge on the psychological 
impact of homelessness in children. Using the PRISMA model, we 
performed a review of the currently available literature on the 
psychological impact of homelessness on children.
Our study highlights violence, aggression and poor academic 
learning outcomes to be just some of the key findings in our review 
of homelessness in childhood, worldwide. Unfortunately, there 
has been minimum research to date on paediatric homelessness 
within the context of the Irish population. We anticipate this 
review to be the first chapter in a multipart series investigation to 
evaluate the psychological morbidity of paediatric homelessness 
within the Irish society.
Risk of repetition and subsequent self-harm following 
presentation to hospital with suicidal ideation: a longitudinal 
registry study
Griffin E, Kavalivdou K, Bonner B, O’Hagan D and Corcoran P 
(2020) EClinicalMedicine, 23: 100378. 
https://www.drugsandalcohol.ie/32147/
The aim of this study was to establish the risk of repeat 
presentation to hospital following suicidal ideation and to identify 
factors which were associated with further ideation or subsequent 
self-harm.
During the period April 2014 to March 2019, a total of 14,695 
presentations to hospital due to suicidal ideation were made 
in Northern Ireland. The cumulative incidence of repeat 
presentation to hospital was 40.5% within five years, with an 18.3% 
risk of subsequent self-harm. Previous ideation had the strongest 
association with repeat presentation. There was evidence of 
recidivism considering further ideation, with an increased risk 
according to number of previous presentations. In contrast, risk 
of subsequent self-harm was highest after the first or second 
presentation. Male gender and alcohol were associated with 
further ideation, while females and young people were more likely 
to re-present with self-harm.
Recent publications   continued
Experiences of stigma in healthcare settings by people living 
with HIV in Ireland: a qualitative study
Vaughan E, Power M and Sixsmith J (2020) AIDS Care, 32(9): 
1162–1167. 
https://www.drugsandalcohol.ie/32237/
This study examined the stigma experiences in healthcare settings 
of people living with HIV (PLHIV) in Ireland. 
The findings indicate experiences of enacted, anticipated and 
internalised stigma were common. A further finding of spatial 
stigma was also uncovered. Analysis showed these experiences 
impacted participants' engagement with care and affected health-
seeking behaviours and treatment adherence. The results suggest 
stigma experienced in healthcare settings may impact negatively 
on health outcomes.
Caring for opioid drug users during the COVID-19 pandemic:  
a commentary on the Irish experience
Crowley D and Cullen W (2020) Heroin Addiction and Related 
Clinical Problems, Early online. 
https://www.drugsandalcohol.ie/32214/
This study aims to describe and discuss the associated evidence 
for the measures implemented to reduce the risks associated with 
COVID-19 to Irish OAT [opioid agonist treatment] services.
Irish OAT services have implemented the following measures: 
reduced supervision requirements, increased the use of virtual 
patient care, streamlined assessment and induction processes 
to remove barriers to OAT access, provided home delivery 
of medications, increased access to naloxone and overdose 
programmes, targeted health and social interventions for the 
homeless and reduced our prison population. For now, non-
essential services including drug and blood-borne virus screening 
and hepatitis C treatment have been postponed. Planning and 
review of Irish OAT services is ongoing so that further adaptations 
can be implemented as challenges emerge.
Establishing prison-led contact tracing to prevent outbreaks of 
COVID-19 in prisons in Ireland
Clarke M, Devlin J, Conroy E, Kelly E and Sturup-Toft S (2020) 
Journal of Public Health, 42(3): 519–524. 
https://www.drugsandalcohol.ie/32262/
This paper describes the approach to contact tracing taken by the 
Irish Prison Service (IPS).
A partnership approach with development of prison-led CTTs 
[contact tracing teams] can provide an effective mechanism for 
contact tracing of COVID-19 cases within the prison setting.
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Economic evaluation of five tobacco control policies across 
seven European countries
Leão T, Perelman J, Clancy L, Mlinarić M, Kinnunen JM, Nuyts PAW, 
et al. (2020) Nicotine & Tobacco Research, 22(7): 1202–1209. 
https://www.drugsandalcohol.ie/32240/
We assessed the cost-effectiveness of five tobacco control 
policies (nonschool bans, including bans on sales to minors, bans 
on smoking in public places, bans on advertising at points-of-
sale, school smoke-free bans, and school education programs), 
implemented in 2016 in Finland, Ireland, the Netherlands, Belgium, 
Germany, Italy, and Portugal.
All five policies were highly cost-effective in all countries according 
to the World Health Organization thresholds for public health 
interventions. Cost-effectiveness was preserved even when using 
the highest costs and most conservative effectiveness estimates.
A study to assess smoking habits and smoking exposure in 
sportspeople
O’Sullivan B, Scully P, Curtin RJ and Plant BJ (2020)  
QJM: An International Journal of Medicine, Early online. 
https://www.drugsandalcohol.ie/32239/
We aimed to ascertain the prevalence of tobacco consumption in 
a sporting population. We also endeavoured to quantify the use of 
e-cigarettes and assess exposure to passive smoking.
The prevalence of smoking in our study population was higher 
than other literature reports. Further studies are essential to 
evaluate the potential negative effects this may be having on 
sporting performance, career progression and indeed injury 
occurrence/rehabilitation. It is imperative to address the matter 
of smoking in athletes, not only for public health concerns but also 
considering they are important role models in our society.
News media and the influence of the alcohol industry: an 
analysis of media coverage of alcohol warning labels with a 
cancer message in Canada and Ireland
Vallance K, Vincent A, Schoueri-Mychasiw N, Stockwell T, 
Hammond D, Greenfield TK, et al. (2020) Journal of Studies on 
Alcohol and Drugs, 81(2): 273–283. 
https://www.drugsandalcohol.ie/32152/ 
The purpose of this study was to examine the framing of news 
coverage of alcohol warning label (AWL) initiatives that included a 
cancer message on alcohol containers in two different countries. 
Policy contexts and industry perspectives were also evaluated.
News coverage of AWLs with a cancer message was more 
supportive in Canada than Ireland, where alcohol industry 
perspectives were consistently foregrounded. Industry arguments 
opposing the cancer label bore similarities across contexts, often 
distorting or denying the evidence. Increasing awareness of 
industry messaging strategies may generate more critical coverage 
of industry lobbying activities and increase public support for 
alcohol policies.
Addiction psychiatry and COVID-19: impact on patients and 
service provision
Columb D, Hussain R and O’Gara C (2020) Irish Journal of 
Psychological Medicine, 37(3): 164–168.  
https://www.drugsandalcohol.ie/32062/
The COVID-19 pandemic has undoubtably had a major impact on 
the provision of physical healthcare in Ireland and worldwide. The 
mental health impact of this pandemic cannot be underestimated, 
particularly relating to patients suffering with addiction. 
Heightened public stress and anxiety levels, increasing isolation 
and the physical consequences of addiction play a large role in 
the proliferation and ongoing relapse of substance misuse and 
behavioural addiction. Service provision is an ongoing challenge 
due to the increasing need for services given the increased 
mental health burden of COVID-19 but also the restrictions in 
place in clinical areas to achieve social distancing. The necessary 
adaptations to service provision provide opportunities for the 
analysis of current processes used in our addiction unit and the 
introduction of new processes to our service. The current crisis 
tests the sustainability of the service to provide the high standard 
of care required for these patients.
Prenatal alcohol exposure and risk of attention deficit 
hyperactivity disorder in offspring: a retrospective analysis of 
the millennium cohort study
Mitchell JM, Jeffri FJ, Maher GM, Khashan AS and McCarthy FP 
(2020) Journal of Affective Disorders, 269: 94–100. 
https://www.drugsandalcohol.ie/32011/
The aim of the study was to investigate the relationship between 
prenatal maternal alcohol consumption and the risk of attention 
deficit hyperactivity disorder (ADHD), the strengths and difficulties 
questionnaire (SDQ) score and abnormal hyperactivity score in 
seven-year-old children.
Light, moderate or heavy antenatal alcohol consumption was not 
associated with an increased susceptibility to ADHD or behavioural 
outcomes in this study. However, due to the limited number of 
cases we cannot rule out an increased risk of ADHD in relation to 
heavy alcohol consumption.
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Evaluation of a Traveller mental health liaison nurse: service 
user perspectives
Keogh B, Brady AM, Downes C, Doyle L, Higgins A and McCann T 
(2020) Issues in Mental Health Nursing, 41(9): 799–806. 
https://www.drugsandalcohol.ie/32010/
A Traveller Mental Health Liaison Nurse (TMHLN) was introduced in 
one health care region in Ireland to provide support for Travellers 
and increase their access to mental health services. The aim of 
this paper is to present the findings from an evaluation which 
explored Travellers' access to and reasons for accessing the 
TMHLN, the interventions provided and their experiences of and 
perceptions of the role of the TMHLN.
The findings highlight how the interpersonal skills associated 
with mental health nursing set against recovery orientated and 
culturally congruent practices are suitable approaches when 
working with Travellers.
Psychological distress, alexithymia and alcohol misuse in 
patients with psoriasis: a cross-sectional study
Founta O, Adamzik K, Tobin A-M, Kirby B and Hevey D (2019) 
Journal of Clinical Psychology in Medical Settings, 26(2): 200–219. 
https://www.drugsandalcohol.ie/31944/
This study investigates (a) the prevalence of psychological distress, 
alexithymia and alcohol misuse in psoriasis patients; and (b) the 
relationship between psoriasis severity, alexithymia, alcohol and 
psychological distress in patients with psoriasis. 
Alexithymia was associated with anxiety, depression and worry; 
subjective psoriasis severity was associated with worry. Alcohol 
misuse was related to anxiety and worry, but not to depression. 
Appropriate identification and treatment of alcohol difficulties and 
psychological distress of patients with psoriasis is needed.
Gambling advertising during live televised male sporting events 
in Ireland: a descriptive study
Columb D, Wong MC, O’Mahony V, Harrington C, Griffiths MD  
and O’Gara C (2020) Irish Journal of Psychological Medicine,  
Early online. 
https://www.drugsandalcohol.ie/32390/
The aim of the present study was to analyze gambling 
advertisements shown during live sporting events broadcast 
in Ireland and to assess these advertisements for responsible 
gambling (RG) practices.
Gambling advertisements are commonly shown during live 
televised sporting broadcasts in Ireland, especially during 
live football matches and typically before the adult television 
watershed. Gambling legislation is required to minimize harm to 
vulnerable groups including children
Recent publications   continued RESPONSES
The mental and physical health profile of people who died by 
suicide: findings from the Suicide Support and Information 
System
Leahy D, Larkin C, Leahy D, et al. (2020)  
Social Psychiatry and Psychiatric Epidemiology, 55: 1525–1533. 
https://www.drugsandalcohol.ie/32384/ 
There is limited research on the associations between factors 
relating to mental and physical health in people who died by 
suicide.
Different factors associated with suicide were identified 
among people with mental and physical illness and those with 
and without a diagnosis, and need to be taken into account 
in suicide prevention. The identified factors highlight the 
importance of integrated care for dual-diagnosis presentations, 
restricting access to means, and early recognition and 
intervention for people with high-risk self-harm.
A clinician's guide to self-poisoning with paracetamol in 
youth: the what, when and why?
Hayden JC, Kelly L and McNicholas F (2020) Acta Paediatrica, 
109(11): 2237–2242. 
https://www.drugsandalcohol.ie/32236/
Deliberate self-poisoning or overdose is a common presentation 
to the paediatric emergency departments (ED) due to a lack of 
emergency access to child and adolescent mental health services. 
We overview medical and psychiatric assessment of overdoses in 
youth with the most commonly implicated drug, paracetamol, as a 
case study.
Given the importance of timely assessment and treatment, 
paediatric emergency staff need to be familiar with the protocol 
for care. Attention needs to be focused on both the medical and 
psychological risk, and staff need to consider the reasons behind 
the overdose, and following a biopsychosocial assessment, ensure 
that the young person and family are adequately signposted for 
future mental health care if needed.
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Distinguishing between contact and administration of 
heroin from a single fingerprint using high resolution mass 
spectrometry
Costa C, Ismail M, Stevenson D, Gibson B, Webb R and Bailey M 
(2020) Journal of Analytical Toxicology, 44(3): 218–225. 
https://www.drugsandalcohol.ie/31930/
Fingerprints have been proposed as a promising new matrix 
for drug testing. In previous work it has been shown that a 
fingerprint can be used to distinguish between drug users and 
nonusers. Herein, we look at the possibility of using a fingerprint to 
distinguish between dermal contact and administration of heroin. 
This research highlights the importance of washing hands prior to 
donating a fingerprint sample to distinguish recent contact with 
heroin from heroin use.
Mobile health technology interventions for suicide 
prevention: systematic review
Melia R, Francis K, Hickey E, et al. (2020)  
JMIR mHealth and uHealth, 8(1): e12516.  
https://www.drugsandalcohol.ie/32322/
This review aimed to examine the effectiveness of currently 
available mobile health (mHealth) technology tools in reducing 
suicide-specific outcomes.
The small number of studies reported in this review tentatively 
indicate that such tools may have a positive impact on suicide-
specific outcomes. Future mHealth intervention evaluations would 
benefit from addressing the following 3 main methodological 
limitations: (1) heterogeneity of outcomes: a lack of standardized 
measurement of suicide outcomes across studies; (2) ecological 
validity: the tendency to exclude potential participants because 
of the elevated suicide risk may reduce generalizability within 
clinical settings; and (3) app regulation and definition: the lack 
of a standardized classification system for mHealth intervention 
type points to the need for better definition of the scope of such 
technologies to promote safe practice.
